| Home > Search > Search by drug > Result | ||||||
| search option: [ drug like %temozolomide% ] | ||||||
| ncRNA_id | ncRNA_name | drug_id | drug_name | cancer | drug response | PMID | details |
| MI0000439 | miR-23b | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 22982144 | more... |
| MI0000489 | miR-195 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 20444541 | more... |
| MIMAT0004784 | miR-455-3p | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 20444541 | more... |
| MIMAT0004555 | miR-10a(*) | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 20444541 | more... |
| MI0000077 | miR-21 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 20633539 | more... |
| MI0000470 | miR-125b-2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 21879257 | more... |
| MI0000077 | miR-21 | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 22753745 | more... |
| MIMAT0004679 | miR-296-3p | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 22999387 | more... |
| MI0000270/MI0000683 | miR-181b | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 23645289 | more... |
| MI0000071 | miR-17 | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 23792642 | more... |
| MI0000446/MI0000470 | miR-125b | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 23857508 | more... |
| MI0000289/MI0000269 | miR-181a | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 24573637 | more... |
| MI0000270/MI0000683 | miR-181b | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 24573637 | more... |
| MI0000271 | miR-181c | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 24573637 | more... |
| MI0003139 | miR-181d | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 24573637 | more... |
| MI0000446/MI0000470 | miR-125b | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 24643683 | more... |
| MI0000446/MI0000470 | miR-125b | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 24901050 | more... |
| MI0000447/MI0000727 | miR-128 | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 25017996 | more... |
| MI0000478 | miR-149 | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 25017996 | more... |
| MI0003138 | miR-497 | DB00853 (APRD00557) | temozolomide | glioma | resistant | 25080009 | more... |
| MI0000283 | miR-203 | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 25515700 | more... |
| MI0000446/MI0000470 | miR-125b | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 26170223 | more... |
| MI0000070/MI0000115 | miR-16 | DB00853 (APRD00557) | temozolomide | glioma | resistant | 26722459 | more... |
| MI0000476/MI0000455 | miR-138 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 26887050 | more... |
| MIMAT0026614 | miR-487b-5p | DB00853 (APRD00557) | temozolomide | lung cancer | resistant | 27097129 | more... |
| MI0000266 | miR-10a | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 27270310 | more... |
| MI0000735 | miR-29c | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 27384876 | more... |
| MIMAT0000722 | miR-370-3p | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 27595933 | more... |
| MI0000103/MI0000739 | miR-101 | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 27792996 | more... |
| MIMAT0004748 | miR-423-5p | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 27471108 | more... |
| MI0000298 | miR-221 | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 27837435 | more... |
| MIMAT0001627 | miR-433-3p | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 27926502 | more... |
| MI0003138 | miR-497 | DB00853 (APRD00557) | temozolomide | glioma | resistant | 28064447 | more... |
| MI0000289/MI0000269 | miR-181a | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 28121023 | more... |
| MI0000283 | miR-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 28187000 | more... |
| MI0000443/MI0000444/MI0000445 | miR-124 | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 28242198 | more... |
| MI0000300 | miR-223 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 28332226 | more... |
| MI0000240 | miR-198 | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 28425046 | more... |
| MI0000270/MI0000683 | miR-181b | DB00853 (APRD00557) | temozolomide | glioblastoma multiforme | sensitive | 28501897 | more... |
| MI0000283 | miR-203 | DB00853 (APRD00557) | temozolomide | melanoma | sensitive | 28597996 | more... |
| MI0000735 | miR-29c | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 28831025 | more... |
| MI0000084 | miR-26b | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 28898169 | more... |
| MI0000449 | miR-132 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 28901390 | more... |
| MIMAT0002809 | miR-146b-5p | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 29048680 | more... |
| MIMAT0004614 | miR-193a-5p | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 29136760 | more... |
| MI0000266 | miR-10a | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 29397407 | more... |
| MI0003649 | miR-634 | DB00853 (APRD00557) | temozolomide | glioma | resistant | 29473317 | more... |
| MI0000103/MI0000739 | miR-101 | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 29479863 | more... |
| MI0006405 | miR-1268a | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 29876787 | more... |
| MIMAT0002890 | miR-299-5p | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 30061180 | more... |
| MI0000809 | miR-151a | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 30102952 | more... |
| MI0003814 | miR-1271 | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 30248541 | more... |
| MI0001150 | miR-196b | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 30610041 | more... |
| MI0000489 | miR-195 | DB00853 (APRD00557) | temozolomide | glioma | resistant | 30273182 | more... |
| MIMAT0000257 | miR-181b-5p | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 30551476 | more... |
| MIMAT0000252 | miR-7-5p | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 30586549 | more... |
| MIMAT0000445 | miR-126-3p | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 30980849 | more... |
| MIMAT0004752 | miR-20b-3p | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENSG00000266835 | lncRNA RP11-838N2.4 | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 27270310 | more... |
| ENSG00000130600 | H19 | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 27366087 | more... |
| ENSG00000177640 | CASC2 | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 28121023 | more... |
| ENSG00000251562 | MALAT1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 28187000 | more... |
| ENSG00000251562 | MALAT1 | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 28187000 | more... |
| ENSG00000251562 | MALAT1 | DB00853 (APRD00557) | temozolomide | Glioblastoma | resistant | 28668966 | more... |
| ENSG00000214548 | MEG3 | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 28791407 | more... |
| ENSG00000229807 | XIST | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 28831025 | more... |
| ENSG00000177640 | CASC2 | DB00853 (APRD00557) | temozolomide | glioma | sensitive | 29136760 | more... |
| ENSG00000251562 | MALAT1 | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 29202181 | more... |
| ENSG00000243197 | TUSC7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 29397407 | more... |
| ENSG00000251562 | MALAT1 | DB00853 (APRD00557) | temozolomide | glioblastoma | sensitive | 29479863 | more... |
| ENSG00000246273 | SBF2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 30992025 | more... |
| ENST00000424980.5 | lnc-TALC | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ERC1-1:5 | lnc-ERC1-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-15K19.2.1-3:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SCG3-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_028415 | LINC00942 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036444 | FENDRR | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602425 | LINC01081-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT025399 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000408207 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HIST1H2BI-1:1 | lnc-HIST1H2BI-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000532168 | LINC02762-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608023 | MIR29B2CHG-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000584952 | AC055811.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000452675 | LINC02541-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000589702 | AC008569.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000600280 | LINC02614-206 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000605056 | AC104695.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000414426 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000548687 | AC025569.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000412321 | AL122058.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CASP5-2:1 | lnc-CASP5-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000580242 | COLEC12-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GABARAPL1-2:1 | lnc-GABARAPL1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HPSE2-1:1 | lnc-HPSE2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DDX51-9:1 | lnc-DDX51-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CSNK1A1-1:1 | lnc-CSNK1A1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027256 | TREML3P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TXNDC12-4:1 | lnc-TXNDC12-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000434560 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002936 | TOB2P1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KCNE4-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000479229 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000431083 | AC099552.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033957 | LINC00842 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PSG4-1:1 | lnc-PSG4-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033519 | MASP1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GPR89B-11:2 | lnc-GPR89B-11:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SMARCAL1-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033925 | FENDRR | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DCDC5-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAM182B-8:10 | lnc-FAM182B-8:10 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DCDC5-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_111000 | LOC101060524 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TIMP4-2:1 | lnc-TIMP4-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026713 | FAM182A | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PIK3CG-2:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033652 | MSC-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000597169 | CCDC194-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HK2-1:10 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033878 | LINC00944 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000568817 | AC104072.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GLOD4-4:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_045121 | DGCR5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033888 | LOC284344 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DHX37-10:24 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC106017.3.1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IFI27L1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000621819 | AC009878.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000535153 | LINC02282-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT098097 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_122045 | LINC02593 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CXCL12-4:1 | lnc-CXCL12-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000589310 | LINC01764-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000523133 | MSC-AS1-209 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC009237.1-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KIF5C-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT087996.2 | NONHSAT087996 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110783 | LINC01444 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033774 | BASP1P1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT023953 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000580867 | LINC01444-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000560727 | AC066613.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036503 | PRKCQ-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_039989 | MIR4458HG | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000562313 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000515614 | LINC00942-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CLEC7A-2:1 | lnc-CLEC7A-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033711 | TP73-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000612143 | AL139384.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-COL6A3-2:1 | lnc-COL6A3-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125841 | LINC01564 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000548213 | LINC01551-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000498714 | FOXP1-IT1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026589 | WHAMMP2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SMARCAL1-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SRGN-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027040 | ATP6V0E2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SMARCAL1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ODZ3-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MGMT-2:1 | lnc-MGMT-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000613389 | AC245041.2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CLEC2A-3:2 | lnc-CLEC2A-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DHRSX-1:2 | lnc-DHRSX-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ANXA8-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024045 | RAET1K | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-UMODL1-1:2 | lnc-UMODL1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000520156 | AC027117.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RUNX2-2:1 | lnc-RUNX2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PSG6-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PDGFRL-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MEGF6-4:1 | lnc-MEGF6-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_045127 | RAET1E-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DCP1B-6:1 | lnc-DCP1B-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_001434 | HLA-H | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000580268 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SMARCAL1-2:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003714 | POM121L9P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000529416 | AP000880.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FABP2-4:1 | lnc-FABP2-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104172 | TMEM132D-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033712 | TP73-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000598518 | IGFL2-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RNMTL1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GPRASP2-1:1 | lnc-GPRASP2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000511928 | LINC02600-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HSFY2-10:1 | lnc-HSFY2-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000580756 | AP000915.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FRMD4A-1:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CCDC167-4:2 | lnc-CCDC167-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026714 | FAM182B | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMEM123-3:2 | lnc-TMEM123-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000582858 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DCP1B-6:2 | lnc-DCP1B-6:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM188A-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GARNL3-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DHX37-10:10 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003521 | WHAMMP3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-THNSL1-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000610135 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DHX37-10:20 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SSTR2-2:1 | lnc-SSTR2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026915 | AADACP1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C3orf65-10:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000424251 | AC003659.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ULBP2-3:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000449075 | THORLNC-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033931 | LINC01085 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000533504 | AP000880.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CCDC93-2:4 | lnc-CCDC93-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033752 | NMRAL2P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000449819 | THORLNC-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NKX6-2-3:2 | lnc-NKX6-2-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLC30A10-12:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000505448 | AC104825.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DEC1-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120335 | LOC101928414 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DDX51-10:1 | lnc-DDX51-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104173 | TMEM132D-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000440726 | LINC02041-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000412812 | AC079630.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000544499 | LINC00944-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_109780 | LINC00513 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000583461 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602761 | LINC02577-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MKI67-2:1 | lnc-MKI67-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CLDN1-2:1 | lnc-CLDN1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CYP4F11-1:1 | lnc-CYP4F11-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000528497 | LINC02697-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000540739 | TMEM132D-AS1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC069257.9.1-4:69 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602900 | AP002840.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MUC4-1:9 | lnc-MUC4-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000617667 | AC087588.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036502 | PRKCQ-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000424493 | AC024560.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KIF5C-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000615979 | AC027348.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026732 | LINC01551 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CLEC2A-3:1 | lnc-CLEC2A-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT144908 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624365 | AL353597.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PITRM1-5:1 | lnc-PITRM1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-C9orf66-7:1 | lnc-C9orf66-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000588307 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000520646 | AC027117.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000599781 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CHSY1-5:5 | lnc-CHSY1-5:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000325042 | AC073072.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FGF9-1:2 | lnc-FGF9-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DHRS2-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026810 | FAM106CP | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC110373.1-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000433673 | MAP3K2-DT-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000486671 | TCL6-209 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CLSTN2-1:1 | lnc-CLSTN2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NIPA1-1:12 | lnc-NIPA1-1:12 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110388 | LINC01186 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000557777 | LINC01579-209 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103738 | SOX9-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000485282 | AC004917.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000472238 | AC121764.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-XAF1-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000527483 | EDRF1-DT-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNHIT6-1:2 | lnc-ZNHIT6-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF716-24:2 | lnc-ZNF716-24:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000453951 | LINC01293-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PSG2-2:1 | lnc-PSG2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC069257.9.1-4:67 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ARRDC3-1:16 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110840 | LOC101927136 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IFI27L1-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000614011 | AC018695.6-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036526 | SUGT1P4-STRA6LP | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-USP35-1:14 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-COPS4-1:2 | lnc-COPS4-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602695 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000581211 | LINC01444-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026731 | LINC01551 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038996 | USP30-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NYAP2-2:1 | lnc-NYAP2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000455607 | AL355312.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KCNB1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SPTLC1-6:3 | lnc-SPTLC1-6:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT018657.2 | NONHSAT018657 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLCO2B1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000519068 | MSC-AS1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT017486.2 | NONHSAT017486 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000454321 | AL137186.2-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MSC-4:1 | lnc-MSC-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C10orf96-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024583 | POM121L8P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000617916 | AC005393.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RPSAP58-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNHIT6-1:4 | lnc-ZNHIT6-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000613809 | AL139384.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000599817 | IGFL2-AS1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000605044 | AL121917.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_109795 | LINC01508 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000416958 | AC118754.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT125277.2 | NONHSAT125277 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT095934.2 | NONHSAT095934 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FSIP1-5:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000605513 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000515153 | AC012625.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_130766 | BISPR | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046357 | RNF165 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PCM1-4:4 | lnc-PCM1-4:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000618848 | AC243829.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024591 | POM121L1P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602332 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZDHHC11B-1:1 | lnc-ZDHHC11B-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CLSTN2-1:2 | lnc-CLSTN2-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-METTL19-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PIWIL4-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000563933 | LINC02555-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-OLR1-1:1 | lnc-OLR1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC092327.1-2:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000615212 | MUC20-OT1-249 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ADA-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNHIT6-1:3 | lnc-ZNHIT6-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110292 | SNHG31 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT004347.2 | NONHSAT004347 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024405 | LOC730101 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_126334 | LOC101927932 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-XAF1-1:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000576252 | AC087392.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027003 | LOC93429 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000422204 | AC116366.2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-OBFC2A-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000444114 | LINC01638-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MIPOL1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GABARAPL1-2:2 | lnc-GABARAPL1-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FTSJD2-1:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000582363 | LINC00667-206 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KANK1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000441841 | LINC02243-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000428329 | AC007319.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026576 | SAA3P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZHX3-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SCUBE1-2:1 | lnc-SCUBE1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GBP6-3:1 | lnc-GBP6-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_040070 | LOXL1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TIMM10-1:1 | lnc-TIMM10-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125792 | LINC01291 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PSG2-4:1 | lnc-PSG2-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_015440 | PRDM16-DT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HK2-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_037888 | STX18-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SGCE-1:4 | lnc-SGCE-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_028044 | IGF2-AS | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CRIPT-4:1 | lnc-CRIPT-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609207 | LINC02593-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ARHGAP29-7:1 | lnc-ARHGAP29-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000420508 | AP000550.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ABCA4-2:1 | lnc-ABCA4-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZDHHC2-2:1 | lnc-ZDHHC2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DEC1-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026913 | LY6E-DT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CABP4-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000574560 | AC087392.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-AIPL1-1:2 | lnc-AIPL1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-STIM2-10:1 | lnc-STIM2-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ARHGEF1-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CCDC89-6:1 | lnc-CCDC89-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PTPLB-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000512133 | TMEM132D-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607794 | AC004233.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000571302 | AC005736.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103535 | NEXN-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_040091 | LOC100506990 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-NTSR1-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CLDN1-1:1 | lnc-CLDN1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CALCRL-2:1 | lnc-CALCRL-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF674-1:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033939 | SCOC-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IFI44-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FGL1-3:8 | lnc-FGL1-3:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SBF2-1:2 | lnc-SBF2-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000522244 | AC104248.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046836 | HS1BP3-IT1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125365 | LINC02595 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CXorf28-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C8orf47-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003268 | CTAGE10P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000567108 | AC109449.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC112721.1.1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_126160 | FAM106B | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-BMP7-1:1 | lnc-BMP7-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000586961 | AC011476.3-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602981 | AC087203.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027064 | TINCR | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CDKN2B-2:2 | lnc-CDKN2B-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000616245 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026791 | HCG27 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SHB-1:1 | lnc-SHB-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLC39A11-2:21 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103859 | LINC01082 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CUL5-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ITGAX-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000412872 | AL713998.1-214 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ANKRD27-10:1 | lnc-ANKRD27-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038969 | PPP1R26-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT117917.2 | NONHSAT117917 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000600197 | MUC20-OT1-238 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000620056 | AC243829.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000512647 | AC012613.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000610389 | AC105105.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAM3B-3:2 | lnc-FAM3B-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024431 | ZMIZ1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZSCAN12-2:1 | lnc-ZSCAN12-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LTBP1-1:1 | lnc-LTBP1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF674-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT137714 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000503263 | AC106795.2-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT080492.2 | NONHSAT080492 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034096 | FTCDNL1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GLOD4-4:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000612098 | MUC20-OT1-248 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CSF1R-1:1 | lnc-CSF1R-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IFI27L1-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000454537 | AC012501.2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624506 | FP236315.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SOHLH2-3:1 | lnc-SOHLH2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033884 | HTATSF1P2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_109819 | NR2F1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RBFA-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606179 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-NBR2-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000528717 | AP001830.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-EID3-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC25A41-3:1 | lnc-SLC25A41-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110226 | HECW2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033298 | CCDC163 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002307 | MSX2P1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125805 | TMEM92-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000415590 | SFTA1P-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C14orf126-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_105045 | LINC01843 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ARHGAP15-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DEC1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-BAHD1-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NCOA3-9:2 | lnc-NCOA3-9:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DNAJC3-2:1 | lnc-DNAJC3-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SNX13-2:6 | lnc-SNX13-2:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607326 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT103586.2 | NONHSAT103586 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ARRDC3-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_122105 | MIR570HG | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SPO11-1:5 | lnc-SPO11-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CCRN4L-8:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GLRX3-13:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RPGR-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-EIF3M-2:11 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RBM27-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MKLN1-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_119376 | FER1L4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-NPR3-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_028295 | LINC00029 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DHX37-10:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_029193 | SH3RF3-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PRICKLE2-3:2 | lnc-PRICKLE2-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-JPH4-3:1 | lnc-JPH4-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HLA-A-5:1 | lnc-HLA-A-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026597 | DIRC3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-LIPG-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HSBP1L1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000569927 | AC114811.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SGCE-1:1 | lnc-SGCE-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMEM74-1:2 | lnc-TMEM74-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000612806 | AC013564.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_109825 | NR2F1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RNF113B-9:1 | lnc-RNF113B-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-THUMPD1-3:1 | lnc-THUMPD1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110724 | LINC01480 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606841 | AC116312.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CDHR4-4:3 | lnc-CDHR4-4:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120412 | LMO7-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RXFP2-3:1 | lnc-RXFP2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000423466 | AC026355.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000538329 | AC092112.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000582591 | AP000919.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KATNB1-1:1 | lnc-KATNB1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000473550 | DUBR-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120549 | WT1-AS | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC073263.1-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000568776 | AC105411.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-INTS10-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-METTL19-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606778 | AC016877.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624769 | AC093535.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FRMD4A-4:1 | lnc-FRMD4A-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT118258.2 | NONHSAT118258 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM176A-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT116540.2 | NONHSAT116540 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000584608 | AC005828.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TBC1D7-2:1 | lnc-TBC1D7-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606272 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ERAP2-7:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C17orf48-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608615 | AP000345.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000514752 | SLC7A11-AS1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT054059 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120592 | PRSS23 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024356 | FBLL1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GGT1-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609975 | AC009237.14-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_045484 | LOC646626 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602175 | MUC20-OT1-245 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-C6orf106-1:1 | lnc-C6orf106-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000586248 | LINC00662-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000433644 | FANCC-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000454799 | FAM66C-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DERA-4:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_111906 | LOC100506175 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LHFPL4-4:1 | lnc-LHFPL4-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT004238.2 | NONHSAT004238 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SCRN3-10:1 | lnc-SCRN3-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GPR143-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-EIF3A-1:1 | lnc-EIF3A-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DMTF1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000555771 | AC005476.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-IMP4-7:1 | lnc-IMP4-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CASP4-1:2 | lnc-CASP4-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-NECAB2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ADIPOR2-3:1 | lnc-ADIPOR2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-LTBP1-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-YLPM1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103549 | LUCAT1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLC12A8-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C8orf31-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000619523 | AC245041.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120598 | GACAT2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT017225 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_126004 | LINC02762 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ARRDC3-1:13 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110611 | LINC01752 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_045116 | C5orf56 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-POM121L7-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606434 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-NARG2-7:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CLINT1-3:1 | lnc-CLINT1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MAP9-11:1 | lnc-MAP9-11:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TMEM178-1:14 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLC2A13-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-C1orf52-2:1 | lnc-C1orf52-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000619182 | TCL6-213 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000397551 | PAXIP1-AS2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TIGD4-3:1 | lnc-TIGD4-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026874 | LINC02593 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034079 | CASP17P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM188A-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624395 | Z95114.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_001590 | IFITM4P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000434300 | AL390957.1-206 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DKK1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002727 | RFPL1S | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000501520 | AC138904.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110806 | LINC01969 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608032 | AP000919.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000527511 | LINC02762-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-WISP2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MASTL-3:2 | lnc-MASTL-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT108933.2 | NONHSAT108933 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608412 | AC058791.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT031866 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT118058.2 | NONHSAT118058 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT054054 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SPTLC3-5:1 | lnc-SPTLC3-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLC22A5-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_028301 | DUBR | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000513626 | LUCAT1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-COPS4-1:1 | lnc-COPS4-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SAMD4A-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-WSB1-5:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NUDCD2-8:1 | lnc-NUDCD2-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110326 | MAP3K14-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C16orf53-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000449168 | AC096649.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104644 | LINC01204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033346 | BOK-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CDH18-13:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_037176 | PSMB8-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110671 | DEPDC1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000605007 | AC018638.6-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036466 | LINC00987 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_077228 | MTHFD2P1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MRGPRF-6:1 | lnc-MRGPRF-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CXorf36-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_037184 | NSMCE1-DT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027622 | LOC100128164 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NKX2-5-7:1 | lnc-NKX2-5-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NCOA3-9:5 | lnc-NCOA3-9:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C9orf29-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SUMF2-8:1 | lnc-SUMF2-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000395900 | WT1-AS-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_048547 | MGST1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000605534 | AL121917.1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000444586 | AL513210.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-LUC7L3-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000503602 | AC004803.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CA4-1:1 | lnc-CA4-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C9orf93-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125775 | LURAP1L-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RLIM-2:24 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TCF19-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607057 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000589518 | AC008105.2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C8orf42-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZDHHC2-6:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CADM1-7:1 | lnc-CADM1-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000560197 | AC013652.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-JAKMIP2-1:1 | lnc-JAKMIP2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000483218 | AC019068.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000604491 | AC097634.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IFI27L1-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT033089.2 | NONHSAT033089 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TTC30B-1:6 | lnc-TTC30B-1:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT054092 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000600642 | AL137002.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LAMA4-3:1 | lnc-LAMA4-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607586 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CADM2-6:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000517833 | LY6E-DT-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000599382 | AC245884.8-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FABP2-2:1 | lnc-FABP2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000517482 | AC090192.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000559008 | AC016705.2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RNF135-1:16 | lnc-RNF135-1:16 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SP110-2:1 | lnc-SP110-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000570945 | MIR193BHG-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GPR143-3:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033315 | BDNF-AS | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000537616 | AC010186.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000570843 | AC108134.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C9orf102-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CARD6-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF705A-3:1 | lnc-ZNF705A-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC069257.9.1-4:30 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000454380 | AC116366.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-OBFC2A-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SCARB2-2:5 | lnc-SCARB2-2:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607837 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000605233 | POC1B-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000520185 | AC007991.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609272 | FAM106A-212 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027000 | LINC00965 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RASD1-2:1 | lnc-RASD1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000591892 | AL031320.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000579138 | AC005544.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM172A-2:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103852 | TAT-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_108105 | CT66 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120467 | LOC101928416 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TNPO3-1:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MED14-5:1 | lnc-MED14-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C4orf34-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT056405.2 | NONHSAT056405 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000444077 | AC017006.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000529938 | LINC02762-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-BEND7-1:3 | lnc-BEND7-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC16A14-3:1 | lnc-SLC16A14-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT054078 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RAG1-5:1 | lnc-RAG1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624364 | AP001528.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104646 | LINC02405 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026659 | LOC727896 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000499322 | AC105285.1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000618708 | MUC20-OT1-251 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_121212 | LINC01507 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PTPRG-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000440492 | LINC02574-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000613779 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PPP1R12A-3:1 | lnc-PPP1R12A-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000601033 | AC007785.3-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000520863 | AC108863.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IFI44-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-C17orf51-1:9 | lnc-C17orf51-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GTDC1-25:1 | lnc-GTDC1-25:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033972 | LINC02709 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104643 | FLJ32255 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000450890 | ITGB1-DT-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MUC4-1:8 | lnc-MUC4-1:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-YARS2-3:1 | lnc-YARS2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AFAP1L1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000469484 | WNT5A-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000612967 | C5orf56-206 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FARSB-8:2 | lnc-FARSB-8:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CGGBP1-3:1 | lnc-CGGBP1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103548 | LUCAT1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CORO2A-1:1 | lnc-CORO2A-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GBP3-2:1 | lnc-GBP3-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM138A-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MKL2-1:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KCNJ5-2:1 | lnc-KCNJ5-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ATP6V1G2-DDX39B-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000449473 | AC093157.1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607679 | AL354872.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110856 | LOC101928516 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT054101 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000473756 | LINC00973-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TLE2-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000470427 | DENND6A-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DUOXA2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TNK2-7:8 | lnc-TNK2-7:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DNAJB9-5:1 | lnc-DNAJB9-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-XPO4-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000581471 | LINC00667-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000407772 | HCG27-206 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ERMAP-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000535242 | AC138466.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT054102 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000568827 | AC092338.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HIRIP3-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000526642 | NAV2-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RBM45-2:1 | lnc-RBM45-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024125 | ATP1A1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-C2CD2L-1:1 | lnc-C2CD2L-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_028471 | APOOP5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000565689 | LOXL1-AS1-207 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GPR155-2:1 | lnc-GPR155-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_126057 | LINC02520 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000533672 | AP001528.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000511794 | LINC02057-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMEM50B-4:1 | lnc-TMEM50B-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027082 | SFTA1P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624848 | AC016397.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AL353597.1-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000369884 | WBP1L-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FBXO15-3:4 | lnc-FBXO15-3:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MAPK6-12:4 | lnc-MAPK6-12:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000490162 | LINC02577-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT136246 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_028594 | ZNF833P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000506664 | LINC00461-206 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024126 | ATP1A1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PPM1N-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF8-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000391000 | AL135998.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FYCO1-3:1 | lnc-FYCO1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_015389 | LINC00667 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000600062 | AC097717.1-243 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DLC1-2:1 | lnc-DLC1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000494869 | AC063952.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000613598 | AC002094.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000619983 | AC138466.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CCL4L1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC233263.1-7:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-UGT3A2-1:1 | lnc-UGT3A2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MUC2-1:1 | lnc-MUC2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024399 | SNAI3-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606034 | AL645608.7-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM110A-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000610252 | AC009237.15-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033947 | LIMD1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SGCE-1:3 | lnc-SGCE-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000616851 | AC243649.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KLF15-3:4 | lnc-KLF15-3:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000510240 | AC010285.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-VWC2L-1:5 | lnc-VWC2L-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000445201 | LINC01138-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623125 | AC093908.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003133 | GBP1P1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000449486 | PAXIP1-AS2-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033867 | LOC392232 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C3orf79-4:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAM110B-1:9 | lnc-FAM110B-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000518552 | AC018607.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000565937 | AC009065.5-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000456634 | LINC00029-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF674-1:10 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT024013 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MZT2A-17:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ISM1-3:1 | lnc-ISM1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000488040 | AC092944.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000566535 | NSMCE1-DT-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110473 | LINC-PINT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HCN2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-VAV3-3:1 | lnc-VAV3-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000515895 | AC142283.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RAG1-5:3 | lnc-RAG1-5:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KB-1507C5.2.1-3:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HNRNPA1L2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-BMP7-1:3 | lnc-BMP7-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DHX8-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-AGBL3-1:1 | lnc-AGBL3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000591365 | AC008105.3-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000620892 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103839 | FRY-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CDRT1-1:1 | lnc-CDRT1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GPR143-3:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-973F15.1.1-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM5B-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF470-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_040068 | LOXL1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CNPPD1-1:1 | lnc-CNPPD1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TCL1B-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-USP9X-8:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-APIP-1:2 | lnc-APIP-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-WDR31-1:2 | lnc-WDR31-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ITPA-2:1 | lnc-ITPA-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000581452 | DSG1-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-XAF1-1:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TOM1L2-1:1 | lnc-TOM1L2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608064 | AC093726.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000457075 | BX284668.5-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ABHD10-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RNASET2-2:1 | lnc-RNASET2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC069257.9.1-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MYL12B-3:2 | lnc-MYL12B-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_073453 | LINC00601 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033709 | TP73-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-INSL4-8:1 | lnc-INSL4-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608943 | AC006566.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC114947.1.1-2:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-OBFC2A-9:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026809 | FAM106A | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-OBFC2A-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DGCR2-3:1 | lnc-DGCR2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PDGFRB-1:2 | lnc-PDGFRB-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DHX57-6:1 | lnc-DHX57-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000440629 | AP001432.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLC2A10-11:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RPAP2-1:2 | lnc-RPAP2-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SUMF2-9:1 | lnc-SUMF2-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000427598 | KCNK15-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000457233 | MUC20-OT1-221 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GRIK5-1:2 | lnc-GRIK5-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000376617 | AC148477.3-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NKAIN3-9:1 | lnc-NKAIN3-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ACOT12-5:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MKLN1-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NEUROG3-3:1 | lnc-NEUROG3-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PTPRG-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000615677 | WT1-AS-208 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_015436 | LINC00461 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000471057 | FAM182A-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623655 | ERICD-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000582865 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MZT2A-1:1 | lnc-MZT2A-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000438195 | LINC01358-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SEPT9-1:4 | lnc-SEPT9-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033369 | LINC01056 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ATP10A-8:1 | lnc-ATP10A-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-WDR5-2:2 | lnc-WDR5-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CATSPER3-5:1 | lnc-CATSPER3-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000562763 | AC009097.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000477059 | LINC01391-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-POM121L12-2:2 | lnc-POM121L12-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT054060 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC110373.1-8:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ST3GAL6-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000413185 | EPCAM-DT-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ATM-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000578280 | AC004585.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC45A1-6:1 | lnc-SLC45A1-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000415144 | AL138831.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-C6orf201-2:6 | lnc-C6orf201-2:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000614580 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000478367 | WT1-AS-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000583253 | AP005136.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TRIM2-1:1 | lnc-TRIM2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046451 | LOC374443 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000561822 | PRKCQ-AS1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DPH5-2:2 | lnc-DPH5-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KIAA0930-4:6 | lnc-KIAA0930-4:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038308 | LINC01094 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CDH18-15:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000426023 | AC022034.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KIF1C-3:1 | lnc-KIF1C-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000525548 | AP002433.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000565041 | AC005606.2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000574654 | AC137056.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000554029 | AL359233.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-BCL7C-1:3 | lnc-BCL7C-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000415285 | AL160153.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FBXO15-6:3 | lnc-FBXO15-6:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002163 | OR7E37P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PTPN7-2:1 | lnc-PTPN7-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT116907 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CRHR1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZFP90-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-APTX-2:3 | lnc-APTX-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT059510.2 | NONHSAT059510 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT140817.2 | NONHSAT140817 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AP001496.1-1:13 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-BIRC2-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAM83A-5:1 | lnc-FAM83A-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ERICH1-9:3 | lnc-ERICH1-9:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC112721.1.1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SNX32-1:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608737 | MUC20-OT1-247 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SIPA1L1-3:1 | lnc-SIPA1L1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HIST1H2BJ-5:1 | lnc-HIST1H2BJ-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SOD2-3:3 | lnc-SOD2-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000533179 | SOX9-AS1-211 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MFSD8-8:4 | lnc-MFSD8-8:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024402 | SNAI3-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF461-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SPATA5-1:2 | lnc-SPATA5-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027178 | SNHG29 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000455309 | AC017002.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000517910 | GASAL1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000448740 | DSE-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-EIF4E3-7:1 | lnc-EIF4E3-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-USP14-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT053955 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000441568 | LINC01747-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT108292 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MYNN-8:1 | lnc-MYNN-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TNFSF18-1:2 | lnc-TNFSF18-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000616826 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607314 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PLEKHA5-5:1 | lnc-PLEKHA5-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-VMP1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CDH18-14:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_047479 | CCDC200 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ABCD3-1:2 | lnc-ABCD3-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000581117 | AP006565.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DDX5-4:1 | lnc-DDX5-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000605502 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HIST1H3D-1:1 | lnc-HIST1H3D-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000505978 | AC005823.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TUB-5:1 | lnc-TUB-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000545508 | LINC00944-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RBM11-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_021492 | CHKB-DT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-VCAN-2:1 | lnc-VCAN-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623796 | AL359183.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002174 | CMAHP | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AIM1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609553 | AC096992.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000514145 | LINC02021-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000358234 | AC011450.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000420096 | OGFRP1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_028288 | TCL6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DDX47-3:1 | lnc-DDX47-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CABP4-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000445420 | KCNK15-AS1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLC6A20-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-EPN2-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TPP2-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120365 | TMC3-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CTH-10:1 | lnc-CTH-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TRIO-1:1 | lnc-TRIO-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000510523 | AC105285.1-208 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ERC2-2:1 | lnc-ERC2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623371 | AC099494.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024476 | PAXIP1-AS2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033864 | CYP4F24P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000617238 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_126419 | P3H2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034123 | CKMT2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RPUSD2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AP002414.1.1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GLIPR1-5:1 | lnc-GLIPR1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-AGAP1-3:2 | lnc-AGAP1-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-XXYLT1-4:1 | lnc-XXYLT1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000538219 | LINC00987-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-LARP1B-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAM208A-1:2 | lnc-FAM208A-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000432045 | AC016831.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT136340 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HNRNPH1-5:1 | lnc-HNRNPH1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MIPOL1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ANKRD27-9:1 | lnc-ANKRD27-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LRRC58-5:1 | lnc-LRRC58-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_028287 | GABARAPL3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ALG9-1:1 | lnc-ALG9-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SMAD2-3:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF705D-3:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033343 | PSCA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NMT2-2:2 | lnc-NMT2-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110953 | LINC01504 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GPRIN2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_121649 | LINC01391 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602431 | AC125494.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DNAJB4-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-B3GNT9-2:1 | lnc-B3GNT9-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046101 | LINC01545 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NRP1-2:1 | lnc-NRP1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000431981 | AL133410.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RBM27-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FER1L6-1:2 | lnc-FER1L6-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GUCY1A3-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000560419 | AF111167.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SPTLC3-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CDC123-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000415026 | AP001468.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000611330 | AC010492.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT076729 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_028138 | ATP2B1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ORMDL3-1:1 | lnc-ORMDL3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF582-5:6 | lnc-ZNF582-5:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624529 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CEP120-6:1 | lnc-CEP120-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CXCL3-1:1 | lnc-CXCL3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MFAP5-1:1 | lnc-MFAP5-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RBM45-1:1 | lnc-RBM45-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_037884 | LOC100507053 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RNF6-4:1 | lnc-RNF6-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000615200 | AL049692.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LRRC58-5:3 | lnc-LRRC58-5:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DNAJB6-3:1 | lnc-DNAJB6-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_123740 | RIMKLB | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000579057 | LINC00271-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110952 | LINC01504 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SYF2-4:2 | lnc-SYF2-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DHRSX-3:1 | lnc-DHRSX-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC110373.1-8:15 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CARD16-1:1 | lnc-CARD16-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GIMAP5-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120506 | LINC01510 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT118268 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC091435.1-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CAPZA3-3:2 | lnc-CAPZA3-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000422542 | SNHG26-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MTRNR2L4-2:1 | lnc-MTRNR2L4-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF623-1:1 | lnc-ZNF623-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606160 | AL450270.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046450 | LOC374443 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DNAJB12-4:1 | lnc-DNAJB12-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF658-2:2 | lnc-ZNF658-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_073180 | LIPE-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLAIN1-6:1 | lnc-SLAIN1-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000526906 | AC080023.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027916 | AKR1C8P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-IKZF2-3:5 | lnc-IKZF2-3:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC092327.1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C10orf10-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TNFSF18-2:1 | lnc-TNFSF18-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SORCS2-2:1 | lnc-SORCS2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000478845 | AC037198.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DEC1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SHC3-6:3 | lnc-SHC3-6:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RPL30-4:1 | lnc-RPL30-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110384 | PLS3-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110177 | NCK1-DT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AP000974.1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GCSH-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PSG6-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000614782 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KLF15-2:5 | lnc-KLF15-2:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GDA-2:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000419211 | AC015987.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000561746 | AP000766.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000461864 | NCK1-DT-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000610021 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_051988 | FBXW10 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PSG4-2:1 | lnc-PSG4-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CALM2-2:9 | lnc-CALM2-2:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HIST2H3PS2-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CYB5A-2:1 | lnc-CYB5A-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000620519 | AC092747.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GCNT6-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SMCHD1-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HNRNPA3-1:1 | lnc-HNRNPA3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ERICH1-9:4 | lnc-ERICH1-9:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-WDR31-1:1 | lnc-WDR31-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000575792 | MIR193BHG-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SFMBT1-1:1 | lnc-SFMBT1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000541749 | LINC02387-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602443 | AF131215.7-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TNK2-7:7 | lnc-TNK2-7:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RBCK1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_015378 | ZNF674-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GIMAP6-2:1 | lnc-GIMAP6-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RPLP1-5:1 | lnc-RPLP1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000619353 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF720-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024394 | LINC00689 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM106B-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000538731 | LINC02361-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC069257.9.1-4:29 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027329 | PSMG3-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_047507 | HOXC13-AS | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TRIM39-RPP21-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT054103 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038911 | MIF-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000612616 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT031729.2 | NONHSAT031729 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C10orf28-7:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000457813 | AC018685.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAM19A1-3:1 | lnc-FAM19A1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MFSD8-6:1 | lnc-MFSD8-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036569 | STAG3L5P-PVRIG2P-PILRB | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AL713998.1-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000454253 | Z99916.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602554 | AC011450.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027097 | LINC00486 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT054083 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MZT2A-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_015379 | UCA1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZFP57-7:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MKL2-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PTBP1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TCL1B-3:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000560743 | AC013652.1-206 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000499459 | AC008966.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMEM69-1:1 | lnc-TMEM69-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607175 | AL021807.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000419832 | AC073323.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000622847 | AL122023.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PQLC2-1:1 | lnc-PQLC2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602739 | AC009108.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TSC22D2-4:1 | lnc-TSC22D2-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_004401 | SEC1P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TSHB-2:1 | lnc-TSHB-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000469070 | AC092910.3-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DHX38-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623752 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000561826 | AC092142.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608162 | AP005432.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GPR83-3:1 | lnc-GPR83-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000533697 | AP003032.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CEP89-1:2 | lnc-CEP89-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000599770 | AC243960.3-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000362361 | AC069285.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_015341 | SMURF2P1-LRRC37BP1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KIAA1210-4:1 | lnc-KIAA1210-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SAP30-15:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000580993 | AC008088.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607876 | AL135910.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000503052 | AC020661.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000529127 | AC103855.2-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125975 | WARS2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036533 | LOC100499489 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-OGFOD1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC17A5-2:1 | lnc-SLC17A5-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TRPM1-3:1 | lnc-TRPM1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000617006 | AC008622.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CLEC2D-8:7 | lnc-CLEC2D-8:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GJE1-3:2 | lnc-GJE1-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000415536 | AC003092.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ERCC6L-2:1 | lnc-ERCC6L-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HSF4-1:1 | lnc-HSF4-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PRELID2-1:4 | lnc-PRELID2-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ERAP2-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SDSL-9:1 | lnc-SDSL-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046662 | ADIPOQ-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HOXD13-3:2 | lnc-HOXD13-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000571639 | MIR193BHG-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZHX1-5:1 | lnc-ZHX1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC002365.1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036522 | ZNF667-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000552663 | LINC02356-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CD302-2:1 | lnc-CD302-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602488 | CCDC18-AS1-224 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ERC1-2:1 | lnc-ERC1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-XRN2-8:1 | lnc-XRN2-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CLVS1-1:5 | lnc-CLVS1-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TPH2-5:1 | lnc-TPH2-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000581677 | AP000845.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT135090.2 | NONHSAT135090 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000621984 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CETP-2:1 | lnc-CETP-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GLRX-3:1 | lnc-GLRX-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZC3HAV1L-1:1 | lnc-ZC3HAV1L-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DNAL1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000559277 | TMC3-AS1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000613210 | AC004494.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SNX10-6:1 | lnc-SNX10-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CDKN3-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PPP1R13L-2:1 | lnc-PPP1R13L-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_102326 | HCG18 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623999 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DCBLD1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_037602 | LINC01578 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_044999 | OR7E12P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_037875 | MAP4K3-DT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DCAKD-2:1 | lnc-DCAKD-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-OR51B4-3:2 | lnc-OR51B4-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PAIP1-2:1 | lnc-PAIP1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609315 | AL359091.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ERAP2-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000565523 | AC023824.5-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-WFDC3-1:1 | lnc-WFDC3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GPT2-12:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-NOC2L-8:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CCDC43-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT108638 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034072 | SARS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-NUCB2-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120686 | LINC01503 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027501 | BCDIN3D-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000620563 | AC096708.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT119334.2 | NONHSAT119334 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000454980 | AP000695.2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000518539 | KBTBD11-OT1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-COLEC12-4:3 | lnc-COLEC12-4:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_130742 | FAM86EP | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ENPP1-5:3 | lnc-ENPP1-5:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CLDN16-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAM117B-6:1 | lnc-FAM117B-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026827 | LINC00839 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000495691 | AC007952.8-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CENPJ-1:6 | lnc-CENPJ-1:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000566575 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF192-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000548691 | AC079598.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PPP1R2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TSC22D2-3:1 | lnc-TSC22D2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-AFAP1-2:1 | lnc-AFAP1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002569 | SCARNA9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606796 | AL096865.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MC5R-1:2 | lnc-MC5R-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MEGF10-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RNF31-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024489 | LOC100129534 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000445534 | AC112715.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AP000350.4.1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-IQGAP2-4:1 | lnc-IQGAP2-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026955 | NRAD1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CNNM1-3:1 | lnc-CNNM1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-BCAT1-3:1 | lnc-BCAT1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CHST7-5:1 | lnc-CHST7-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NKD2-3:8 | lnc-NKD2-3:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000616774 | AC092119.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000620493 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GPR143-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GRB14-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027425 | FAM66D | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000509548 | LINC02512-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000582527 | AC132825.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000573896 | SPACA6-208 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104462 | CENPW | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CCDC144A-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CHD2-11:1 | lnc-CHD2-11:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000577218 | AC068025.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000548901 | AC011595.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TMEM133-5:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609288 | AC131235.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TDO2-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000625115 | CU633904.1-206 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026921 | LOC202181 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624846 | CU638689.4-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000547042 | AC005841.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ERI3-1:1 | lnc-ERI3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GCNT6-5:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LRRTM1-7:1 | lnc-LRRTM1-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C5orf39-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CCT5-15:1 | lnc-CCT5-15:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PIGZ-1:1 | lnc-PIGZ-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000455986 | NKAP-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000468859 | LINC02614-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ST6GALNAC5-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000577798 | COX10-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT023699 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MYO18B-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033969 | PLCE1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RPRML-3:15 | lnc-RPRML-3:15 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RPS12-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MTSS1L-1:1 | lnc-MTSS1L-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034089 | CCDC18-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000512538 | SLC7A11-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000585780 | MAP3K14-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000511543 | FAM13A-AS1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002779 | NUDT9P1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125364 | MKLN1-AS | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CENPW-3:1 | lnc-CENPW-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624610 | AC007342.7-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-STAG1-5:1 | lnc-STAG1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000562696 | AC092115.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623064 | AC011466.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000436672 | AL356277.3-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FXYD6-2:1 | lnc-FXYD6-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MAMSTR-1:1 | lnc-MAMSTR-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C3orf14-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PZP-6:2 | lnc-PZP-6:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CST7-5:1 | lnc-CST7-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CCDC144C-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000533670 | LINC02754-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036485 | SBF2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C14orf135-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MRPS5-12:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607350 | AL512329.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-BLACE-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CRCP-3:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602790 | AC005479.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608029 | AC106052.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000363024 | AC093872.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FBXO44-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NCOA3-23:1 | lnc-NCOA3-23:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SERP1-1:1 | lnc-SERP1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-COBLL1-1:1 | lnc-COBLL1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT070320.2 | NONHSAT070320 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RAET1E-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000387419 | MT-TD-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000512978 | LINC02100-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000433747 | AC073529.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000567614 | AC244090.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027120 | HSD52 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SPRED2-11:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-STAG1-1:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-EBF3-2:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609514 | AL355512.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-IL5-1:2 | lnc-IL5-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000425820 | AL138789.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AHNAK-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC109486.1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_105006 | LINC01111 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZBTB17-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036581 | TMEM238L | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000496842 | AC080013.1-207 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TK2-8:1 | lnc-TK2-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_028062 | PRKY | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-UCN2-2:2 | lnc-UCN2-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623593 | AC145098.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027413 | LINC00910 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAM156B-1:1 | lnc-FAM156B-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LPAR6-4:1 | lnc-LPAR6-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000530049 | AC116021.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ASNS-1:9 | lnc-ASNS-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C15orf54-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-EIF2B5-6:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC007401.2.1-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT117915 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000447430 | LINC00513-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038905 | FZD4-DT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000479612 | LINC00882-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MUC19-2:1 | lnc-MUC19-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CACNG5-2:1 | lnc-CACNG5-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PREX2-2:1 | lnc-PREX2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KB-1980E6.3.1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000541092 | AP000786.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LEF1-3:6 | lnc-LEF1-3:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000549961 | AC084879.1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000522970 | AC007991.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602575 | AF131215.6-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RAB40B-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SUSD1-2:1 | lnc-SUSD1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000437416 | AC096537.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026835 | FLJ37201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HLA-C-4:1 | lnc-HLA-C-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000458463 | Z99756.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607421 | U47924.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KNTC1-3:1 | lnc-KNTC1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PLSCR2-5:1 | lnc-PLSCR2-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000605886 | AL365181.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000499900 | AC139795.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DDX60L-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GPATCH8-2:1 | lnc-GPATCH8-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608985 | AC097717.1-244 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ANXA11-1:1 | lnc-ANXA11-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DGCR2-1:1 | lnc-DGCR2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C10orf96-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000458080 | Z93930.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HLA-A-7:2 | lnc-HLA-A-7:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000591569 | BLOC1S3-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DMGDH-1:3 | lnc-DMGDH-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PSORS1C2-1:2 | lnc-PSORS1C2-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CCP110-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HSD17B14-4:1 | lnc-HSD17B14-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMEM50B-3:1 | lnc-TMEM50B-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_109821 | NR2F1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RND3-4:1 | lnc-RND3-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT008794 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RNF135-1:12 | lnc-RNF135-1:12 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SF3B5-3:1 | lnc-SF3B5-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CCDC54-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CPN1-1:1 | lnc-CPN1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GLUD2-14:1 | lnc-GLUD2-14:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000436600 | CT66-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-UBE2E3-9:1 | lnc-UBE2E3-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000440326 | MYOSLID-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KAT7-5:1 | lnc-KAT7-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RIBC2-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-STXBP4-1:3 | lnc-STXBP4-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT108241 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000556035 | AL132709.7-207 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000458509 | TH2LCRR-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ACADL-1:1 | lnc-ACADL-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-WDR27-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110012 | LINC00211 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000577678 | AC099850.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002929 | LOC148709 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000509194 | AC093801.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_130107 | GHET1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000430416 | AC019080.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HDAC2-2:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026675 | CRYM-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PPIAL4C-9:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NFE2L2-1:3 | lnc-NFE2L2-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC011497.1-2:11 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-171N4.2.1-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C15orf60-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FDXACB1-3:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DERA-4:2 | lnc-DERA-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_040092 | LOC100506990 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C3orf65-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000537288.1 | A2ML1-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CCDC17-5:1 | lnc-CCDC17-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZFP62-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000619354 | AC099521.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FDXACB1-3:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606963 | AC100814.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027626 | CMAHP | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FRMD6-2:2 | lnc-FRMD6-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026730 | TPTE2P1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000559857 | AC090907.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CTD-2117L12.1.1-4:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TBXAS1-4:1 | lnc-TBXAS1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PSG2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000391200 | AC087893.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NCOA3-5:9 | lnc-NCOA3-5:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TEFM-8:1 | lnc-TEFM-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_015360 | LINC01184 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HIATL1-19:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NIPA1-1:14 | lnc-NIPA1-1:14 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000603533 | AL161729.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027995 | ANKRD20A9P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DCAKD-1:3 | lnc-DCAKD-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FCHO2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002806 | FAM13A-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000616043 | LINC02614-215 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DCUN1D5-5:1 | lnc-DCUN1D5-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_037183 | SPANXA2-OT1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TSC22D2-1:3 | lnc-TSC22D2-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000597199 | LINC01480-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TTC30B-4:1 | lnc-TTC30B-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DMAP1-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CKS2-3:2 | lnc-CKS2-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-OSBPL6-2:14 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PRDM4-6:4 | lnc-PRDM4-6:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000612219 | AC008013.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000622426 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046268 | TGFB2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GCNT6-5:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ATP6V1H-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PDHX-5:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-166B2.1.1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAM83A-7:1 | lnc-FAM83A-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAM49B-9:1 | lnc-FAM49B-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT125967 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000554634 | AC005476.2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_109822 | NR2F1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000618824 | AC103691.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000451213 | AC093157.1-206 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623222 | AL022069.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000612367 | AC009163.6-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608916 | AC073529.1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TDRD3-12:1 | lnc-TDRD3-12:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NRSN1-5:1 | lnc-NRSN1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PLS1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026575 | GK3P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-STAG3L4-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC31A1-1:1 | lnc-SLC31A1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMEM241-4:1 | lnc-TMEM241-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000442355 | AC007952.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CCDC167-2:1 | lnc-CCDC167-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-EDAR-5:1 | lnc-EDAR-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ARRDC2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NUP43-1:1 | lnc-NUP43-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PSMB3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624087 | AC131212.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMEM41B-4:1 | lnc-TMEM41B-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000427169 | LINC02806-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ASNS-1:1 | lnc-ASNS-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC104024.2.1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000518993 | AC090152.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CEP63-4:1 | lnc-CEP63-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000595525 | AC004597.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606660 | LINC02609-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C11orf75-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CALCOCO2-9:1 | lnc-CALCOCO2-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000512754 | LINC01085-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TLR1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SMAD5-9:1 | lnc-SMAD5-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C17orf104-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ARMC1-3:1 | lnc-ARMC1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ACOT12-5:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TAB2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609349 | AC012360.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C16orf62-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SIRT7-1:3 | lnc-SIRT7-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003028 | SNORA25 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT023638.2 | NONHSAT023638 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000604982 | AC112220.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110035 | LOC100996671 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GDF10-3:1 | lnc-GDF10-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FDXACB1-3:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000551187 | AC044802.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000434919 | SFTA1P-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002171 | OR7E156P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000390787 | MIR761-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-LINC00293-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000578929 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MRPS28-3:12 | lnc-MRPS28-3:12 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034132 | LINC00939 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000470348 | AC087071.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LEAP2-4:1 | lnc-LEAP2-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GPR183-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AL137145.1-2:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110204 | CHROMR | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034077 | THAP9-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104147 | LOC100996447 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CXorf38-3:1 | lnc-CXorf38-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-EEF1A2-1:3 | lnc-EEF1A2-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ACYP2-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000617424 | AC114778.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000518024 | LY6E-DT-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT116905 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FNBP4-5:1 | lnc-FNBP4-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CPEB2-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-C9orf129-2:1 | lnc-C9orf129-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TNP1-5:4 | lnc-TNP1-5:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606279 | AC087045.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-BTBD1-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000621471 | AC103858.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002451 | ABCA11P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_023380 | CCDC144CP | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000524252 | AC100800.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PRAGMIN.1-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF699-2:2 | lnc-ZNF699-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PRELID2-1:6 | lnc-PRELID2-1:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-UGDH-1:1 | lnc-UGDH-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-AGMAT-5:1 | lnc-AGMAT-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DDX5-3:2 | lnc-DDX5-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ACSM3-1:3 | lnc-ACSM3-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002147 | MYH16 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FGL1-3:2 | lnc-FGL1-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000573315 | LINC00514-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110944 | LINC02182 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM22E-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000439057 | KDM4A-AS1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000556024 | AL121790.2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF259-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RNF135-1:11 | lnc-RNF135-1:11 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000613067 | AC097634.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-AKR1C3-1:1 | lnc-AKR1C3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000451762 | WDFY3-AS2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IFITM2-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000436488 | AC140481.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623871 | AC148477.7-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MYL12B-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608576 | AC073529.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RAG1-4:1 | lnc-RAG1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000487238 | AC092944.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MYO19-1:3 | lnc-MYO19-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SAG-7:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110037 | LOC100996437 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_108045 | LINC00867 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM19A1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT013575 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM106A-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003190 | USP32P1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000366405 | ZPR1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027424 | FAM66E | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PLEKHA2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000429315 | KIF9-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FERMT2-4:1 | lnc-FERMT2-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-C5orf22-7:1 | lnc-C5orf22-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PTCH2-1:1 | lnc-PTCH2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_040033 | LINC01915 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000622374 | AC131025.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000620494 | LINC02340-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000563574 | AL135818.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_126038 | LRRC37A8P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ANGPT2-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C17orf28-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-BDNF-6:1 | lnc-BDNF-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GAPVD1-2:1 | lnc-GAPVD1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CA5B-1:3 | lnc-CA5B-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF572-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103855 | LOC100506258 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FRMPD2-3:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PARN-10:1 | lnc-PARN-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RNASET2-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PDE4B-1:1 | lnc-PDE4B-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DNAJC19-5:8 | lnc-DNAJC19-5:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAM104A-3:1 | lnc-FAM104A-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PML-1:1 | lnc-PML-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000622740 | LINC01551-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CCDC114-2:3 | lnc-CCDC114-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GPR27-11:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-AATF-2:1 | lnc-AATF-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000563434 | AL138756.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-NUS1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CGA-4:1 | lnc-CGA-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000415338 | AC239798.2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RCOR2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMUB1-1:2 | lnc-TMUB1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DDX19B-2:1 | lnc-DDX19B-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZZZ3-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SEC22A-2:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TEX9-2:1 | lnc-TEX9-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PIGY-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000532890 | MIR100HG-218 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026966 | LOC100130691 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FOXO3-4:1 | lnc-FOXO3-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SCIMP-1:7 | lnc-SCIMP-1:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125377 | LOC100288798 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PLSCR2-5:3 | lnc-PLSCR2-5:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-UCHL1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000497961 | AC112496.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038847 | LINC00672 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C17orf69-2:18 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT054095 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GTF2E1-1:1 | lnc-GTF2E1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000418546 | AC016831.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLC9A7-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT108567 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DPP6-6:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SNAP47-1:3 | lnc-SNAP47-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000620737 | MUC20-OT1-252 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CTD-2049J23.3.1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PATL2-1:1 | lnc-PATL2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GJA10-11:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC091435.1-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000530303 | AP000679.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000584431 | AP000919.2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FBLN2-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PENK-2:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FMO4-3:1 | lnc-FMO4-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZRSR2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-BCL10-1:1 | lnc-BCL10-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TXNDC2-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C12orf53-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT106550 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624958 | AL359510.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000551271 | AL928654.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000479311 | LINC01118-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LARP6-4:1 | lnc-LARP6-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000613715 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AHR-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC25A21-3:1 | lnc-SLC25A21-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT095731.2 | NONHSAT095731 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ANKIB1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MTCH1-3:1 | lnc-MTCH1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-BRI3-2:1 | lnc-BRI3-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000573982 | AC006111.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000501702 | LINC01184-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DHRS12-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-COLEC12-4:2 | lnc-COLEC12-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C9orf21-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_122107 | KU-MEL-3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DNTTIP2-2:1 | lnc-DNTTIP2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000543486 | AP003170.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CYP11B2-1:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NME5-2:1 | lnc-NME5-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TRH-7:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-USP44-2:1 | lnc-USP44-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623816 | AC040160.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-UBQLNL-1:1 | lnc-UBQLNL-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AP001793.1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC004696.1-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000445235 | AC069542.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110997 | MIR3936HG | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000525473 | ALG1L9P-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000516910 | AL356785.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TNFSF8-2:1 | lnc-TNFSF8-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000488720 | FLNB-AS1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RABGGTB-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602736 | AC012065.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000384676 | AC023950.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000466740 | AC141424.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HSPB11-1:1 | lnc-HSPB11-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KCNJ14-1:1 | lnc-KCNJ14-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NR1I2-1:4 | lnc-NR1I2-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FREM1-1:1 | lnc-FREM1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ACOT12-5:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CDC42SE1-1:2 | lnc-CDC42SE1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608028 | AC069222.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000596963 | AC010139.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038236 | LINC00968 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CRYGN-3:2 | lnc-CRYGN-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038991 | RBM26-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C9orf95-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C21orf63-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000614150 | AL354950.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606048 | AC107952.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000559410 | AC016595.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAIM3-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-BDNF-7:1 | lnc-BDNF-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MADD-2:1 | lnc-MADD-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MBOAT1-3:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PPAPDC2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_015359 | WDFY3-AS2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103495 | GIGYF2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000453011 | AC093157.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MCART1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PHF15-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000499178 | AP002026.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF483-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000433110 | AL158166.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TRH-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607153 | AC073065.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608396 | OLMALINC-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000610185 | AP000894.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MORC3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000452844 | MUC20-OT1-218 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000553425 | AL121790.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_039985 | FLJ22447 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046632 | NHS-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000625142 | AL022393.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TMC3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000413496 | AC008440.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000584649 | AC090844.3-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110472 | LINC-PINT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000384688 | AL022724.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RNASEH2C-1:1 | lnc-RNASEH2C-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RCAN2-2:1 | lnc-RCAN2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000617833 | SNHG22-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HDHD1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-IL5RA-15:1 | lnc-IL5RA-15:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000534036 | NAV2-AS3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000554558 | KTN1-AS1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SYT1-10:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ELF5-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000550029 | AC025265.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-WDR73-3:7 | lnc-WDR73-3:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C1orf229-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000554678 | AL355075.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CXorf69-3:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT090840 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NUDT21-5:1 | lnc-NUDT21-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-UBL3-5:1 | lnc-UBL3-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000564977 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000501397 | AP001351.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034125 | C10orf143 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC5A6-2:1 | lnc-SLC5A6-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000514291 | LIFR-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RAD1-1:1 | lnc-RAD1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SPG20-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TUBE1-1:1 | lnc-TUBE1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMPPE-2:1 | lnc-TMPPE-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026902 | RBM48 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PIGN-6:1 | lnc-PIGN-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_037597 | LOC442028 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120593 | PRSS23 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KDELC2-2:1 | lnc-KDELC2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000520885 | AC040970.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000568593 | AC099778.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_109943 | LINC01273 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-IGFBP3-1:1 | lnc-IGFBP3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT106613 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C4orf34-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TRIB3-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PABPC1L-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ABCC5-2:1 | lnc-ABCC5-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAP-3:1 | lnc-FAP-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF366-17:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_073568 | GHRLOS | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000581533 | AC005304.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_130941 | LNPK | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-706O15.1.1-8:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HLA-A-3:1 | lnc-HLA-A-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000419614 | LINC01701-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TOX3-7:1 | lnc-TOX3-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000525309 | AC090159.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DCDC1-5:5 | lnc-DCDC1-5:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000410513 | RN7SKP56-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C3orf65-8:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GJE1-3:5 | lnc-GJE1-3:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CA5B-1:6 | lnc-CA5B-1:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000423323 | COX10-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_130179 | LOC100421746 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_073080 | PHLDA3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_001564 | XIST | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ST8SIA5-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT101069.2 | NONHSAT101069 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027457 | LINC00221 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_047570 | PAX8-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038435 | HOXD-AS2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000446630 | AL731683.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RBP1-1:1 | lnc-RBP1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SEL1L2-3:1 | lnc-SEL1L2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034119 | LINC00460 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000435264 | BX927168.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036442 | CEROX1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KIAA1462-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000520819 | AC090204.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FMN2-4:1 | lnc-FMN2-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000422956 | PAX8-AS1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NEUROD6-7:3 | lnc-NEUROD6-7:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MOG-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038346 | MAGI2-AS3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000424850 | AL035541.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SSX1-5:1 | lnc-SSX1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034031 | LOC389906 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CREB5-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-XAGE1C-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000620019 | AL031651.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CREM-2:1 | lnc-CREM-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-1220K2.2.1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_028366 | SSX6P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120607 | LINCR-0003 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HLA-DRB1-4:1 | lnc-HLA-DRB1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_023915 | IPW | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000580278 | CCDC144NL-AS1-213 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SDIM1-3:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000456563 | BX890604.2-212 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034133 | LINC02864 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT117807.2 | NONHSAT117807 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026860 | LINC00473 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RRM2B-7:3 | lnc-RRM2B-7:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003336 | SNORD116-22 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027409 | GOLGA8A | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103835 | LINC02584 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-706O15.1.1-1:13 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110720 | LINC01535 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024553 | ZNF204P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TIMM21-12:1 | lnc-TIMM21-12:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027049 | ZNF788 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003329 | SNORD116-14 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609265 | AL031587.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_122034 | LINC01419 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000622592 | AP003900.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026664 | MGC16025 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DAOA-4:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_040028 | ZNF790-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038434 | LOC100506474 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF506-8:1 | lnc-ZNF506-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ADD2-2:1 | lnc-ADD2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000560097 | AC104041.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000440315 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000430471 | AC096677.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000506106 | AC025470.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_029420 | LOC650226 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038279 | LINC00665 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CDC73-9:1 | lnc-CDC73-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PPP1R3F-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT075636.2 | NONHSAT075636 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-VTI1A-3:1 | lnc-VTI1A-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624858 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003330 | SNORD116-15 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027767 | TNIK | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZBTB20-5:1 | lnc-ZBTB20-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110468 | HAGLR | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000567197 | LINC02562-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_073432 | CSAG4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_015377 | PAX8-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000617955 | MAGI2-AS3-221 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF570-2:1 | lnc-ZNF570-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000581862 | AC079062.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003338 | SNORD116-24 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ATF7IP2-3:7 | lnc-ATF7IP2-3:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CHRM3-1:5 | lnc-CHRM3-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C11orf44-15:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000435024 | LINC00460-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GPBP1-5:1 | lnc-GPBP1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PTPRD-7:1 | lnc-PTPRD-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027291 | NAP1L6P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-LEMD1-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000555300 | AL136018.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-USP51-5:1 | lnc-USP51-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-VN1R4-3:1 | lnc-VN1R4-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000483854 | BX890604.2-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_109758 | LINC02315 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606809 | AL109659.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000600644 | AC021504.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000433732 | XIST-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ABCE1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP3-377D14.1.1-3:19 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002785 | GNAS-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000424415 | BX890604.2-215 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033838 | LOC158435 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026656 | LINC02381 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000521718 | AC022784.1-207 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000534117 | LINC01301-207 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000432783 | AL449403.1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000598084 | LINC01198-206 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ALX1-2:4 | lnc-ALX1-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000458394 | CUTALP-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000458001 | GAS6-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000557618 | AL049874.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003334 | SNORD116-20 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000622757 | AL133325.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026861 | LINC00473 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FLT3-2:2 | lnc-FLT3-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026776 | LOC100270746 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SHROOM4-3:1 | lnc-SHROOM4-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125751 | TBX2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-BAI3-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000617888 | LINC01971-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF534-1:2 | lnc-ZNF534-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000514811 | AC011389.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FANCC-6:1 | lnc-FANCC-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NEUROD6-7:2 | lnc-NEUROD6-7:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120647 | LINC01515 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TSEN2-4:1 | lnc-TSEN2-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_073396 | ZNF818P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_122077 | LERFS | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110618 | NFIA-AS2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-APLN-1:3 | lnc-APLN-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT138945 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FANK1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FEZ1-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF827-8:1 | lnc-ZNF827-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623737 | AC078925.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000435485 | LINC01505-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CDK20-4:2 | lnc-CDK20-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000603198 | AL162413.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000584273 | LINC01956-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034100 | LINC00668 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000584544 | AC079062.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DCAF4L2-3:1 | lnc-DCAF4L2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000567527 | AC124312.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_037595 | HHIP-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000498731 | SOX2-OT-218 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_075092 | SOX2-OT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT070687 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000431060 | AC015712.6-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000603720 | AC017033.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_126355 | LINC01389 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024493 | SMIM10L2B | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104228 | LINC00632 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-AP1S3-1:1 | lnc-AP1S3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-XAGE1C-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT118504 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_001280 | PCDHB17P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000552826 | LINC02588-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-AMY1B-5:1 | lnc-AMY1B-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000596766 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RPL7-4:1 | lnc-RPL7-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GLYATL3-2:3 | lnc-GLYATL3-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_108107 | FAM230B | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-AMY1B-6:1 | lnc-AMY1B-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-POTED-4:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C20orf197-3:13 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125740 | LOC100505938 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000622987 | AC018445.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FOXG1-9:1 | lnc-FOXG1-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000524132 | AC090809.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-1220K2.2.1-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF527-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027250 | SSX8P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-EXTL1-1:1 | lnc-EXTL1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_109931 | LOC101928796 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000598892 | ZNF528-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000605586 | Z99289.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-OR4E2-7:1 | lnc-OR4E2-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CTDSPL-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT086647 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000593577 | AC021504.1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000601979 | LINC01515-214 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002833 | DPY19L2P1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC040934.1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000493248 | AC004889.1-206 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-LRFN5-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000557067 | AL121821.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GORAB-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000510016 | AC079160.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000498032 | AC112487.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PZP-12:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_075093 | SOX2-OT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM60A-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-AGAP2-1:3 | lnc-AGAP2-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608354 | AC004264.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000559321 | LINC02253-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CD59-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GPR157-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033418 | ZNF542P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002835 | HAS2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000431071 | LINC02476-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000530350 | AC108136.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027278 | FAM230C | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000558254 | AC015712.1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PZP-12:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-XAGE2B-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF502-1:2 | lnc-ZNF502-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110849 | SCAT1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623919 | LINC01667-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038916 | PRR7-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623067 | LINC02109-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LINGO2-3:1 | lnc-LINGO2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000446720 | AC112178.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110546 | LINC02298 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TUBB-14:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NOVA1-9:4 | lnc-NOVA1-9:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000443593 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CABIN1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SGIP1-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120606 | LINCR-0002 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000425271 | AL596087.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CTNNA2-3:2 | lnc-CTNNA2-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103850 | CASC9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-NACA2-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_130763 | LOC102723968 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002795 | HOXA11-AS | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MRPS9-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-BCAT1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-POU3F2-5:1 | lnc-POU3F2-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SNURFL-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000577841 | CCDC144NL-AS1-208 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GLYAT-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036484 | FEZF1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000610941 | AC016597.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000412639 | LNCTAM34A-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-OGFR-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT001996.2 | NONHSAT001996 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TUBA3C-9:2 | lnc-TUBA3C-9:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT071500 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026869 | LINC00052 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000363883 | AC004130.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CDK20-4:1 | lnc-CDK20-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000604994 | AC106900.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC22A16-1:1 | lnc-SLC22A16-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000514769 | LINC02163-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000451350 | AC012368.1-206 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | cdr1-as_homosapiens_1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000422996 | AC064875.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606154 | Z97200.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | ara_hg_1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000412855 | LINC01703-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000512343 | RASGEF1B-209 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120426 | LINC01198 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024359 | SMIM10L2A | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RNF187-3:3 | lnc-RNF187-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF527-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAM69B-2:1 | lnc-FAM69B-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000508752 | FAM198B-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM60A-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000429109 | AC093151.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000523050 | AC008464.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-POTEC-5:2 | lnc-POTEC-5:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000561592 | AL031058.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IL28RA-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000507387 | AC010595.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003062 | SPRR2C | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-USP51-5:2 | lnc-USP51-5:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PKN2-2:2 | lnc-PKN2-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM27B-22:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FLT3-2:3 | lnc-FLT3-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-OPRD1-1:2 | lnc-OPRD1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000460407 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MED10-11:4 | lnc-MED10-11:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IRF4-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT034716 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZC3H12B-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000587099 | AC010980.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_015352 | CECR7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CLEC2D-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_023342 | KRTAP20-4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CCNJ-1:8 | lnc-CCNJ-1:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DDT-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046228 | ANKRD20A12P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_037850 | PROX1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000515227 | AC112206.2-209 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609736 | AC253536.6-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP1-177G6.2.1-3:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000442684 | AL445493.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027072 | LINC00189 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KYNU-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000577743 | AC005291.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RNF125-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMEM212-1:2 | lnc-TMEM212-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003551 | DPY19L2P4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-UGT8-1:1 | lnc-UGT8-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-UBE2E3-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_047504 | HOXC-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FOXG1-6:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000515218 | LINC02315-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000528800 | AC079089.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_130772 | ENPP7P13 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP1-177G6.2.1-3:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038220 | LINC00858 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HMCN1-3:2 | lnc-HMCN1-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT088008.2 | NONHSAT088008 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TTC23-4:1 | lnc-TTC23-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000621901 | MAGI2-AS3-225 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000429530 | SCAT8-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000369391 | AL158212.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125909 | LOC101928978 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HIGD2A-1:1 | lnc-HIGD2A-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000616253 | AL353770.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CLEC2D-7:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000443576 | LINC02344-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MRGPRX1-1:1 | lnc-MRGPRX1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT117149 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003337 | SNORD116-23 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000514368 | AC112206.2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_037586 | LINC01549 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMEM14A-2:2 | lnc-TMEM14A-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000527270 | AC113192.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033869 | LINC01060 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF534-1:3 | lnc-ZNF534-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609210 | PAX8-AS1-212 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_028345 | LINC00632 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PEX2-3:1 | lnc-PEX2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ARF6-10:1 | lnc-ARF6-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT117152 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026916 | ANKRD30BP2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024408 | CUTALP | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TRAK1-7:1 | lnc-TRAK1-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003578 | ZNF702P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SMTN-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MINA-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT137258.2 | NONHSAT137258 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024065 | LINC00312 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000551938 | SNHG14-214 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-POLR2F-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PZP-12:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120623 | TCERG1L-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CLGN-5:1 | lnc-CLGN-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM59B-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP1-177G6.2.1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IL17RA-2:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000442796 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-UTS2-5:5 | lnc-UTS2-5:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FHL5-2:1 | lnc-FHL5-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MEF2D-2:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_109948 | LOC101929645 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000559673 | AC015712.4-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SDIM1-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT030854.2 | NONHSAT030854 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000556070 | PAX8-AS1-211 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC011239.1.1-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAM135B-5:1 | lnc-FAM135B-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF33B-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NAA35-1:2 | lnc-NAA35-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000562945 | AC023824.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C19orf63-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000552334 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CLGN-2:1 | lnc-CLGN-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TNFRSF19-5:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000454681 | AL139383.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CTNNA2-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GSX2-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP1-177G6.2.1-1:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104256 | ZFAND4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036438 | SVIL2P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_126023 | OR2A1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DHRS7B-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC10A7-7:1 | lnc-SLC10A7-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLCO5A1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GOLGA7B-1:1 | lnc-GOLGA7B-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C1orf180-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NEUROD6-8:1 | lnc-NEUROD6-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003321 | SNORD116-6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | prins_homosapiens_1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000583852 | AC012588.1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000451574 | FAM230H-207 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SMARCC2-7:1 | lnc-SMARCC2-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RPA3-6:1 | lnc-RPA3-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110026 | LINC01234 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000566457 | AC105046.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000601795 | AL132655.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FFAR1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ASCC1-2:1 | lnc-ASCC1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608389 | AC133041.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C1orf115-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C11orf44-14:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038343 | MAGI2-AS3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC25A14-1:1 | lnc-SLC25A14-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000426965 | HOXD-AS2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT136912 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000437698 | AL139383.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IL28RA-2:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000452037 | LINC01918-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PPP4R1-2:5 | lnc-PPP4R1-2:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CLEC2D-9:1 | lnc-CLEC2D-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RBP1-5:4 | lnc-RBP1-5:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF595-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PAQR9-3:2 | lnc-PAQR9-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103767 | LINC01311 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF595-1:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF345-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CTD-2144E22.5.1-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ABCB5-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000503611 | FAM198B-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-OAZ3-2:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MOK-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003324 | SNORD116-9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AL901608.1-45:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000505196 | LINC01194-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NAPEPLD-5:2 | lnc-NAPEPLD-5:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110764 | LINC01910 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000566366 | AL033527.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PMEPA1-2:1 | lnc-PMEPA1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RNF222-1:1 | lnc-RNF222-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF534-1:4 | lnc-ZNF534-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000420759 | AL445250.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC39A11-1:8 | lnc-SLC39A11-1:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000552101 | LINC02588-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000544842 | AC006206.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-B4GALT6-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_109959 | LINC01687 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT117487 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103783 | BLACAT1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000620859 | LINC01515-217 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000416416 | GORAB-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120659 | LINC01518 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PGGT1B-7:1 | lnc-PGGT1B-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FRG2C-12:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-WARS2-2:1 | lnc-WARS2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607592 | AC116036.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000486571 | BX890604.2-208 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003320 | SNORD116-5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602862 | AC092127.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_121637 | FOXD3-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000598194 | AC020909.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602992 | AC010719.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000574411 | DLGAP1-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-XRCC4-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TGFA-2:1 | lnc-TGFA-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000505537 | TENM3-AS1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AP000708.1.1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000448436 | AL935212.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024391 | MIR924HG | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT121093 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DPY19L2-3:1 | lnc-DPY19L2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DROSHA-9:1 | lnc-DROSHA-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NTSR2-5:7 | lnc-NTSR2-5:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000575647 | AC127496.5-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-BEND7-4:1 | lnc-BEND7-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024420 | LINC00937 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046260 | FAR2P2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DUX4L7-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT103374.2 | NONHSAT103374 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000556405 | LINC02302-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ABCB5-7:1 | lnc-ABCB5-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-VPS41-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000617303 | FAM230G-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046848 | FAM155A-IT1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZBTB20-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_047671 | BANCR | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125345 | ZNF528-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HMCN1-3:1 | lnc-HMCN1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ST6GALNAC3-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZEB2-1:3 | lnc-ZEB2-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SEMA3D-5:2 | lnc-SEMA3D-5:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103854 | LINC01301 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000419440 | AP000844.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C8B-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CLEC18A-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PDIK1L-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000590697 | AC011477.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000467896 | AC092919.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024101 | DLGAP1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PLXNA4-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000554798 | LINC02251-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C6orf138-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000568143 | AL445471.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038371 | LINC01446 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003316 | SNORD116-1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-LINC00273-21:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HOXB4-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_047664 | MEG9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SGIP1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623323 | AC104791.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000581801 | LINC00511-214 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000614771 | NKILA-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000519680 | AC104232.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607594 | AC010424.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000523063 | AF279873.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_130735 | WASIR2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT039999.2 | NONHSAT039999 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038832 | HOXA-AS3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000452769 | DLX6-AS1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000445227 | AL139383.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125856 | LOC101928304 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_126372 | LINC01202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DAXX-1:1 | lnc-DAXX-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TBX20-3:2 | lnc-TBX20-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT071501.2 | NONHSAT071501 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000498693 | AC004889.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C12orf77-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000622616 | AL590227.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027768 | DPY19L2P2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-OR4C13-4:1 | lnc-OR4C13-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TAMM41-4:1 | lnc-TAMM41-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-COL4A5-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HLA-DPA1-2:1 | lnc-HLA-DPA1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FFAR1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000422194 | BX276092.7-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AL033381.1-17:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606069 | LINC02084-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NAPEPLD-5:1 | lnc-NAPEPLD-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000433770 | MACORIS-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLC25A2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027504 | MST1P2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-POTEC-11:3 | lnc-POTEC-11:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000429282 | AC133785.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000433410 | BX276092.7-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000420243 | POU6F2-AS2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NBN-1:1 | lnc-NBN-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125398 | GATA2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026979 | DRAIC | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CCDC140-1:9 | lnc-CCDC140-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_045787 | CERS6-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_040027 | ZNF790-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103532 | RUNX2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000613130 | AC023310.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-WISP1-15:3 | lnc-WISP1-15:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT142064 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MAGEA10-1:4 | lnc-MAGEA10-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000589556 | ZNF790-AS1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000425352 | LINC01739-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SMAD5-4:2 | lnc-SMAD5-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125996 | LINC01770 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000611641 | AL445989.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GTDC1-8:1 | lnc-GTDC1-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036488 | LINC00673 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000441971 | AC002456.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000426547 | AL360175.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TP53TG3-9:2 | lnc-TP53TG3-9:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000513405 | LINC02714-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GLI3-4:1 | lnc-GLI3-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SUMF1-2:4 | lnc-SUMF1-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ATP1B3-1:3 | lnc-ATP1B3-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ARSD-4:1 | lnc-ARSD-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038940 | SH3PXD2A-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TUBE1-5:1 | lnc-TUBE1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ABCE1-5:1 | lnc-ABCE1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ASCC3-7:1 | lnc-ASCC3-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000519764 | AC069120.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623716 | AL390755.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038362 | ZNF345 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-USP9Y-2:2 | lnc-USP9Y-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PPIAL4B-2:20 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF514-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MAP3K8-13:1 | lnc-MAP3K8-13:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HOXA4-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036540 | LINC00622 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF816-2:9 | lnc-ZNF816-2:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HLA-DMA-2:1 | lnc-HLA-DMA-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_130777 | LINC02109 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000505877 | LINC01194-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_040248 | ZEB2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608871 | AL159169.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026658 | LOC100240735 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-VN1R4-2:1 | lnc-VN1R4-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-603J24.9.1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GNAI2-1:24 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110617 | NFIA-AS2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110409 | LOC101928495 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000430988 | AC011239.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PSMD10-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC115989.1.1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000604451 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF503-AS2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TRIML1-3:13 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024369 | CNTFR-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000519655 | AF117829.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125408 | MYEF2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027094 | SYT14P1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-NSDHL-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM86A-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SYT14-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SYN3-1:1 | lnc-SYN3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000430320 | LINC01778-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110120 | LOC101927811 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609742 | AL365203.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-WDFY1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-JMJD4-4:1 | lnc-JMJD4-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF891-1:1 | lnc-ZNF891-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NEUROD6-9:1 | lnc-NEUROD6-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003319 | SNORD116-4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_121647 | LINC01410 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CYP4V2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000584179 | PDE10A-208 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF347-1:1 | lnc-ZNF347-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_037161 | ZNF582-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000612824 | AL138999.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT079642 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038283 | PTPRG-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_122069 | HOXA-AS2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CHIC1-2:1 | lnc-CHIC1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000585765 | AC005746.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000426413 | LINC02476-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000470435 | OR2A1-AS1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000600850 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_036508 | LOC100128398 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZBTB38-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TRIM61-3:1 | lnc-TRIM61-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000513793 | LINC02428-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NID2-5:1 | lnc-NID2-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000513051 | LINC01194-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-OCIAD2-8:1 | lnc-OCIAD2-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-WNT16-2:1 | lnc-WNT16-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000594054 | LINC01515-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602806 | LINC01703-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000514255 | PURPL-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-OMG-1:2 | lnc-OMG-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ARHGAP26-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FFAR1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GSG1L-1:6 | lnc-GSG1L-1:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SREK1-12:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ALX1-3:1 | lnc-ALX1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000417218 | LINC02798-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC008132.1-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DTNA-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606959 | AC010904.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000572855 | AC015909.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-OR4M2-23:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026969 | LINC00326 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000614612 | AL138689.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-APLN-1:2 | lnc-APLN-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM75A6-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000534666 | LINC02722-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000613144 | AMYH02020865.1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CKAP2L-1:6 | lnc-CKAP2L-1:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110919 | LOC101928530 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000598902 | LINC01515-208 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MED1-2:1 | lnc-MED1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PPIAL4G-25:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HIST1H2AI-3:8 | lnc-HIST1H2AI-3:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF677-1:1 | lnc-ZNF677-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PFN2-4:1 | lnc-PFN2-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ACTBL2-1:1 | lnc-ACTBL2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000400023 | C22orf34-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000442666 | PKP4-AS1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SH3RF1-2:1 | lnc-SH3RF1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SPATA6-1:1 | lnc-SPATA6-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ABHD12-1:1 | lnc-ABHD12-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MYEF2-6:1 | lnc-MYEF2-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF503-AS2-11:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000618776 | NR2F2-AS1-214 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000566293 | AL353746.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000445976 | AL583808.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-408E5.4.1-19:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-OR4C11-2:1 | lnc-OR4C11-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607216 | AC244517.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF93-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-AKNAD1-1:2 | lnc-AKNAD1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024462 | RAMP2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000610409 | AC011700.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC084851.1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DGKB-3:1 | lnc-DGKB-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TSPAN12-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000522856 | BAALC-AS1-207 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NDNF-2:1 | lnc-NDNF-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MMD-8:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CKAP2L-1:9 | lnc-CKAP2L-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GPR125-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC145676.2.1-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000589379 | AC011511.5-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000503066 | HHIP-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_121600 | PTPRD-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-24B21.1.1-2:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_015450 | LINC01096 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000454712 | AC078993.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602362 | RP1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-JAK1-6:1 | lnc-JAK1-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000390127 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000574178 | AC027281.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000616473 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CIITA-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT087672.2 | NONHSAT087672 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DLGAP1-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TBC1D8-4:1 | lnc-TBC1D8-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000534431 | AL049629.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-50B3.2.1-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PHGDH-1:1 | lnc-PHGDH-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CPLX1-2:10 | lnc-CPLX1-2:10 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000583184 | AC011825.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000625195 | AC005609.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AL355149.1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002728 | KCNQ1OT1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027433 | LINC01124 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038840 | LINC00693 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103474 | DMC1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000550290 | AC048341.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-272B17.2.1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000590657 | LINC00665-207 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LIN7A-3:1 | lnc-LIN7A-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ATP1A1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TSTA3-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000432621 | AP001347.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GPR180-8:1 | lnc-GPR180-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC45A2-1:1 | lnc-SLC45A2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-UTS2-5:4 | lnc-UTS2-5:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT098514.2 | NONHSAT098514 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | SPRY4-IT1_hg_1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000517927 | MIR3142HG-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000588689 | Z99289.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_111893 | CNTNAP3P2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024484 | LINC00909 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024380 | LOC441666 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CNTN2-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000604183 | AC007029.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM105B-11:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000438322 | LINC00475-207 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000435915 | AL359182.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MB-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000469148 | PTPRG-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000610193 | AC008264.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033871 | FLJ42351 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PF4-1:1 | lnc-PF4-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000540392 | AC022509.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038345 | MAGI2-AS3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ARRDC4-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT087700 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZC3H12B-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000566208 | LINC02152-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IGSF11-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SMC5-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000502209 | AC106771.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000419666 | AL158013.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000455718 | AC244394.2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MRPS6-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CDC26-2:1 | lnc-CDC26-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT122062.2 | NONHSAT122062 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-EMB-6:1 | lnc-EMB-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000613231 | NKILA-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038995 | LINC00327 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_022008 | PWAR5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110846 | LOC101928674 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608373 | AC006946.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KLHL31-2:4 | lnc-KLHL31-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000512036 | AC020551.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110717 | LINC01351 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000490005 | SOX2-OT-211 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000592302 | AC021504.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HOOK2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000612613 | AC091825.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046551 | DLEU7-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RAB3C-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104185 | CCDC144NL-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SNAP91-3:1 | lnc-SNAP91-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RNF150-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624705 | AC109326.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623177 | AC127070.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SUN3-4:1 | lnc-SUN3-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104224 | SH3YL1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000553108 | SNHG14-216 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110457 | HAGLROS | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SNURF-1:30 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CKAP2L-1:4 | lnc-CKAP2L-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PCK1-2:1 | lnc-PCK1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-POLR2B-12:1 | lnc-POLR2B-12:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C2orf89-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PHF19-1:1 | lnc-PHF19-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMEM242-1:1 | lnc-TMEM242-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC008132.1-3:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-160N1.10.1-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609687 | MIR663AHG-234 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000424933 | FRGCA-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TIAL1-1:1 | lnc-TIAL1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-STIL-3:2 | lnc-STIL-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607456 | AC112487.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000431752 | TTN-AS1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000521025 | AC037459.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000500487 | AC068446.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-WSB1-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NME6-2:1 | lnc-NME6-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MTHFD2L-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLC4A3-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT029682.2 | NONHSAT029682 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_130738 | LOC101929719 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP1-32I10.10.1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CCNG1-2:1 | lnc-CCNG1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_126379 | LINC01033 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC015804.1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CDK20-6:1 | lnc-CDK20-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026758 | FAR2P1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003679 | HAND2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KCNJ12-5:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KIAA1614-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000451396 | PROX1-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-160N1.10.1-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CYP4F31P-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_001282 | PCDHB19P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000583460 | LINC00511-216 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-XAGE1C-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-POLI-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110429 | GAPLINC | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-THNSL1-1:1 | lnc-THNSL1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SUCLG1-9:1 | lnc-SUCLG1-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GLG1-3:1 | lnc-GLG1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF583-1:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT012538.2 | NONHSAT012538 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C1orf180-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000620496 | AC009318.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NCOR2-5:1 | lnc-NCOR2-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000619530 | LINC00221-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000435257 | AC002076.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000611334 | AC091825.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609524 | AC107294.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000556750 | AC122685.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000507950 | LINC02121-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000488584 | LINC00886-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RNF217-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125869 | LOC102723883 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003713 | LOC728613 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046873 | TPRG1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ANKRD18A-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FEZF2-9:2 | lnc-FEZF2-9:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DLX6-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000417843 | CR786580.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000565518 | AC068987.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-POLI-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026980 | FRG2DP | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000520306 | AF117829.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000531086 | AP000759.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104603 | CRB2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT081664 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000433734 | LINC02814-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002838 | KC6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FRG1-4:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF595-1:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000524166 | AF117829.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607333 | IER3-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000446213 | AC133785.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000445293 | AC078845.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033963 | HRAT92 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000612025 | AC064801.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607309 | AL360267.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM27B-18:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-EPB41-1:2 | lnc-EPB41-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IL17RA-2:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CMTM6-3:2 | lnc-CMTM6-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FGFRL1-3:1 | lnc-FGFRL1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TMEM188-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC079341.1-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000610171 | AL157904.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC073416.2-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000408413 | RNU6ATAC18P-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000561332 | CCDC33-210 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LYPD5-1:2 | lnc-LYPD5-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TNFSF11-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000581850 | PDE10A-207 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PTTG1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC012414.1-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038378 | LOC441242 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000621571 | AC018445.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000576696 | LINC00327-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SPRY4-3:1 | lnc-SPRY4-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000437551 | PAX8-AS1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038377 | LINC01667 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ANKRD30BL-8:1 | lnc-ANKRD30BL-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026567 | ESPNP | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-BAIAP2L2-1:1 | lnc-BAIAP2L2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000577828 | LINC00511-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000611082 | GAS6-AS1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RG9MTD1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000444476 | LINC00475-208 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027481 | ZNF876P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RPS3A-2:1 | lnc-RPS3A-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125801 | PACERR | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000569677 | AC092376.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TIMP3-2:1 | lnc-TIMP3-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120523 | LOC101928168 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SMC5-10:1 | lnc-SMC5-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ERMP1-3:1 | lnc-ERMP1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TNNT2-3:2 | lnc-TNNT2-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ASB1-4:1 | lnc-ASB1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024059 | MIMT1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CTD-2144E22.5.1-28:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046909 | DENND5B-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_074088 | ATRNL1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-STARD13-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-BRD8-2:1 | lnc-BRD8-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT090850 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RAB1A-8:1 | lnc-RAB1A-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125795 | FOXC2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000453229 | AC103923.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000516424 | RN7SKP253-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000449749 | AC068580.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000502125 | NR2F2-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000399342 | AC005323.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SMAD2-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000510622 | AC122710.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000565938 | AC013565.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FBXO3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000439446 | AC005083.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000453915 | AC116666.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602495 | XIST-208 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000580580 | AC093330.1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LRCH1-5:2 | lnc-LRCH1-5:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038291 | LINC00707 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000510967 | AC096711.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CMTM6-4:2 | lnc-CMTM6-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000551631 | SNHG14-213 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ELOVL5-2:2 | lnc-ELOVL5-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-BRD2-3:1 | lnc-BRD2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PTPN14-3:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000610937 | ZEB2-AS1-212 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000595094 | AC010636.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZBTB38-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000604239 | AC091488.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000618591 | AC023282.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC073416.2-5:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MRP63-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KCNJ3-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608759 | AP000238.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046845 | DNM3-IT1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TRAM1-2:2 | lnc-TRAM1-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KIAA0528-5:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110294 | NCKAP5-AS2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MEX3B-4:3 | lnc-MEX3B-4:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LSAMP-4:1 | lnc-LSAMP-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZFP14-1:19 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CFHR5-6:1 | lnc-CFHR5-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000560314 | LINC02253-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000454735 | AC078845.1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AMBN-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KIAA0528-5:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF469-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT098643.2 | NONHSAT098643 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-NDST3-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606030 | AC244517.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000616832 | AC124319.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NRG1-2:7 | lnc-NRG1-2:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-VSIG7-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FOXD4L4-1:1 | lnc-FOXD4L4-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ASNS-1:10 | lnc-ASNS-1:10 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026989 | LINC01140 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000430586 | AC092168.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623111 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF563-1:1 | lnc-ZNF563-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C6orf164-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-STBD1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MRPL39-35:1 | lnc-MRPL39-35:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM75A6-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000448570 | AC017067.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034128 | LINC01191 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HOXD11-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000561344 | NR2F2-AS1-210 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT138948 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000545923 | AC140847.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624066 | AC018445.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000526703 | LINC02732-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623996 | AC007546.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MST1P9-4:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SMPD1-3:2 | lnc-SMPD1-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-195B21.3.1-2:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624206 | AC134043.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000513899 | VCAN-AS1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000438790 | LINC01778-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CMC1-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-WIPF3-1:4 | lnc-WIPF3-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SOCS6-15:1 | lnc-SOCS6-15:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110273 | ATP6V1B1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CCDC17-1:1 | lnc-CCDC17-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000625066 | AC244517.2-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RCAN1-1:1 | lnc-RCAN1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120420 | LOC100507006 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000428676 | U82695.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM150B-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110084 | LOC101927391 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RPL10L-1:1 | lnc-RPL10L-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AL139008.2-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C20orf7-3:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000442815 | LINC01679-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FOXG1-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_130779 | LOC101928858 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FANK1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF502-1:1 | lnc-ZNF502-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000551565 | AL929601.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TPTE-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000437334 | AL359502.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SMAD7-1:1 | lnc-SMAD7-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PRAMEF11-3:3 | lnc-PRAMEF11-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110702 | SEMA3B-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000414661 | AC064875.1-215 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RNF113B-6:1 | lnc-RNF113B-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PDE4B-1:2 | lnc-PDE4B-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000527726 | AC104031.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KIAA1462-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000564287 | AC092803.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT018709 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FRG1-4:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_109964 | TRPM2-AS | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000500169 | LINC02377-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103451 | LOC101448202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027267 | LINC00310 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000557721 | AL161752.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120436 | WWOX | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CDR1-3:1 | lnc-CDR1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZC3H12B-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000457833 | BX322234.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GLI3-1:2 | lnc-GLI3-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000559428 | AC104041.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ANKRD31-2:1 | lnc-ANKRD31-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000610469 | AC015813.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000560882 | DRAIC-214 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZMAT3-5:1 | lnc-ZMAT3-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000446383 | FGF13-AS1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033829 | MIR4500HG | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000567273 | AL121578.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM105B-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000619646 | AC068234.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MRPL39-37:1 | lnc-MRPL39-37:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000610061 | AL159169.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF569-1:1 | lnc-ZNF569-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF174-1:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CHIC1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000516599 | AC005787.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000615941 | AL445649.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000552781 | SNHG14-215 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000619507 | AC021424.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000615324 | AP001042.1-207 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF816-2:4 | lnc-ZNF816-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LSM5-3:1 | lnc-LSM5-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-262H14.4.1-18:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMEM185A-2:1 | lnc-TMEM185A-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GCNT3-3:3 | lnc-GCNT3-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000584433 | CCDC144NL-AS1-219 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ADAMTS12-2:2 | lnc-ADAMTS12-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000510150 | AC113346.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC073043.2.1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000564121 | AC012508.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000434072 | GNG12-AS1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FOXL1-2:4 | lnc-FOXL1-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PRRC1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-LMNA-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000618162 | AL590096.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000557736 | AL136018.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GTF2A2-6:1 | lnc-GTF2A2-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CHRM3-1:1 | lnc-CHRM3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CCNJ-1:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125973 | LINC01762 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000542084 | DIAPH2-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606899 | BX284668.6-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000438702 | AL117382.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DDC-3:5 | lnc-DDC-3:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609485 | AL592494.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ASB12-1:1 | lnc-ASB12-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000423979 | AC005009.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104179 | LOC100289333 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CHAD-6:1 | lnc-CHAD-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_001281 | PCDHB18P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF2-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104170 | LOC149684 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000531654 | LINC01301-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-WRNIP1-13:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLC25A2-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026830 | SATB2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CXCR3-5:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_029374 | LEF1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000563780 | AC099668.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FOXG1-5:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000622345 | AC090825.1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-OXGR1-6:1 | lnc-OXGR1-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000521872 | AC103952.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026947 | C1RL-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110796 | TTC39C-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602731 | LRRIQ1-208 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000416200 | SATB2-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-LONRF1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000558499 | AC087477.2-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NTSR2-7:1 | lnc-NTSR2-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-POLR3GL-6:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C7orf23-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110809 | LOC101927666 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ALDH3B2-2:1 | lnc-ALDH3B2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SVIL-5:1 | lnc-SVIL-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RALGAPA2-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C14orf166-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000618407 | AC006449.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000524190 | AF117829.1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000570153 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT098131.2 | NONHSAT098131 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000451368 | AC004540.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120453 | ALOX12P2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMEM201-2:1 | lnc-TMEM201-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP3-377D14.1.1-3:23 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT050845 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLC25A2-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125958 | GORAB-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TTC26-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000618697 | AC118658.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_023382 | ZNF815P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000519319 | PCAT1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SSX2B-5:2 | lnc-SSX2B-5:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-LPCAT1-3:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_015419 | LOC145783 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000560056 | LINC02853-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MID1-4:1 | lnc-MID1-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NETO1-1:14 | lnc-NETO1-1:14 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000460400 | AL121721.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ARHGAP5-1:1 | lnc-ARHGAP5-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000589907 | TTN-AS1-235 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FRG1-5:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-EIF2AK3-4:44 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT133370.2 | NONHSAT133370 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ANKRA2-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KIAA0141-3:1 | lnc-KIAA0141-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RPLP1-1:15 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002196 | H19 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FGF9-11:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SERPINI1-17:7 | lnc-SERPINI1-17:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CDH6-2:18 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000584911 | PDE10A-209 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IGSF11-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CREB5-6:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000546968 | LINC02298-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606330 | AC022001.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000620901 | AC004080.12-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000582564 | AC005821.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_015415 | DICER1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC10A7-8:1 | lnc-SLC10A7-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CGNL1-5:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CNTNAP3-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-AMY1B-4:1 | lnc-AMY1B-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MST1P9-4:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_109865 | MRPS30-DT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609596 | CECR7-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-LRMP-10:1 | lnc-LRMP-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HLA-DQA1-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120510 | ELFN1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DLGAP1-2:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000511165 | AC112178.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110753 | LINC02466 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ATG12-8:1 | lnc-ATG12-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TP53TG3-12:1 | lnc-TP53TG3-12:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HDAC9-1:2 | lnc-HDAC9-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SNRPA-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000612365 | AC002401.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-XIRP2-2:1 | lnc-XIRP2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110628 | LOC101926964 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000426044 | AC012618.3-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TMEM144-5:1 | lnc-TMEM144-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TTC26-4:1 | lnc-TTC26-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000505637 | MRPS30-DT-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038278 | LINC00665 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_111908 | MAST4-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C6orf138-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000514073 | AC226119.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HLA-DOA-1:1 | lnc-HLA-DOA-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF729-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C1QTNF9-5:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024358 | LINC00028 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000612495 | AC006538.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609012 | MIR663AHG-230 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SPTSSA-3:1 | lnc-SPTSSA-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000597110 | U62631.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000432518 | RBMS3-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-EGLN1-1:1 | lnc-EGLN1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GOLT1B-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000518749 | AP000426.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606901 | AC005618.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000567129 | AL162412.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PRCD-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-WAC-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003699 | ZNF525 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GINS2-2:2 | lnc-GINS2-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000529082 | AC009652.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606790 | AC254633.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-COL8A1-3:3 | lnc-COL8A1-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024562 | HPN-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CDH10-11:1 | lnc-CDH10-11:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000439795 | LINC02794-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_015448 | DLX6-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT072334 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-STOX2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000586591 | AP001029.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TMEM117-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-USP53-1:3 | lnc-USP53-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000561320 | AC087473.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CPT1A-1:2 | lnc-CPT1A-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000399446 | AL008729.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TMEM194B-5:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000414438 | AC069277.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033766 | FOXP2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CNNM3-3:1 | lnc-CNNM3-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000427022 | AP000317.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC005323.1.1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624350 | AC245060.6-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NUDT4-6:1 | lnc-NUDT4-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CCNYL2-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NCOA3-4:4 | lnc-NCOA3-4:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RSAD2-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000419836 | LINC02663-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PROM1-4:6 | lnc-PROM1-4:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GLYATL2-5:1 | lnc-GLYATL2-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MNS1-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RIPK2-2:1 | lnc-RIPK2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024237 | C2CD4D-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-AGGF1-2:1 | lnc-AGGF1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000527281 | LINC02713-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003260 | DNM1P46 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT003731.2 | NONHSAT003731 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DCT-16:1 | lnc-DCT-16:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-EXOC3L4-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000604818 | AC079610.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602892 | MIR99AHG-217 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000317114 | DLGAP1-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT053925.2 | NONHSAT053925 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-XRCC4-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-408E5.4.1-11:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-YIF1A-6:4 | lnc-YIF1A-6:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000448412 | AL357793.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SPANXN5-2:3 | lnc-SPANXN5-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT055985 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_103717 | LINC01561 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000569134 | AC009812.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-IKZF2-5:1 | lnc-IKZF2-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110682 | PKN2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_104664 | LINC01948 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120533 | LOC101929427 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000561358 | AC103982.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000421509 | AL160272.1-207 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000424735 | LINC01351-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000551067 | AL929601.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000433592 | ID2-AS1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000413145 | AL162411.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GPC5-7:1 | lnc-GPC5-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000616485 | HAND2-AS1-238 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000457457 | AC016735.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-HNRNPR-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000449537 | AC004540.1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000413818 | AL031666.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MND1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC002365.1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-OR4F3-1:1 | lnc-OR4F3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C5orf17-8:13 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC39A11-1:34 | lnc-SLC39A11-1:34 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CTSZ-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003255 | TSIX | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-597K23.2.1-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TGFB1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MYL4-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-YPEL2-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PPIAL4A-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000578787 | AP001025.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-KIAA1967-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623256 | LINC01727-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000618966 | AL161431.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-E2F7-6:1 | lnc-E2F7-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000614633 | AL138995.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000568389 | MAFTRR-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606401 | AC026801.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT000960 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000615831 | AC090510.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IL1RL1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TWIST1-1:3 | lnc-TWIST1-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000588925 | AC027097.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_130923 | LOC102724434 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MRPS6-4:2 | lnc-MRPS6-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000551974 | AC048344.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_001559 | VENTXP1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ST3GAL6-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000431661 | LINC00189-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MSX2-1:2 | lnc-MSX2-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RIT2-2:6 | lnc-RIT2-2:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ARHGAP26-4:8 | lnc-ARHGAP26-4:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ATF3-1:3 | lnc-ATF3-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DRD5-16:1 | lnc-DRD5-16:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623878 | Z97633.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-N4BP2-4:1 | lnc-N4BP2-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RAB4A-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038866 | BSN-DT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024483 | HDHD5-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000437523 | AL592494.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000622621 | AC092376.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-XAGE1D-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AL901608.1-42:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000448887 | FREM2-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FADD-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024366 | FAM225A | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000569860 | AC009486.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GPR137B-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110732 | LOC101928517 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609088 | AC005291.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ABCA12-6:1 | lnc-ABCA12-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CEP170-12:1 | lnc-CEP170-12:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000506465 | PRR7-AS1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-C9orf3-6:1 | lnc-C9orf3-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000518865 | HAS2-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000601445 | AC021504.1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003505 | PPP4R1L | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_027333 | GPR158-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CHRM3-1:6 | lnc-CHRM3-1:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125967 | LINC01719 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000621023 | AC063961.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000414790.6 | H19-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000466893 | PTPRG-AS1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM75A3-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HDAC2-7:1 | lnc-HDAC2-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602419 | BX546450.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC233263.1-12:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000591836 | AC006116.10-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026963 | TTC28-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TIGD6-1:1 | lnc-TIGD6-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000454416 | AC017104.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CHRM2-2:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-EFCAB4B-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT029070 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000566729 | MAFTRR-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RNASEH2B-3:38 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-BMS1-9:1 | lnc-BMS1-9:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000512067 | PURPL-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000608243 | AC104458.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MED1-1:1 | lnc-MED1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000430001 | AF124730.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-NYNRIN-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110839 | LINC02087 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TGFB1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000558641 | AC015712.4-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000590491 | AC092068.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AHR-8:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000620337 | LINC00221-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-IL28RA-2:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GUCA2A-1:1 | lnc-GUCA2A-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000618815 | AC253576.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-LPHN3-8:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000565944 | AC079148.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623570 | AC008103.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MAP1LC3B-7:3 | lnc-MAP1LC3B-7:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000616504 | AC021424.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000562921 | MAFTRR-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KLF14-3:2 | lnc-KLF14-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-80A15.1.1-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT123414.2 | NONHSAT123414 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000586478 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000450783 | AL445524.1-206 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002809 | LINC01089 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RAB5A-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000612818 | AC087893.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110523 | C22orf34 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AMDHD2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AGBL1-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TSPY10-10:1 | lnc-TSPY10-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF184-3:1 | lnc-ZNF184-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110904 | ITFG1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-WRNIP1-13:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-EPSTI1-10:1 | lnc-EPSTI1-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623777 | AC009336.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RPS6KA3-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NPL-2:2 | lnc-NPL-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606221 | AL445647.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GNAI2-1:22 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SFPQ-2:5 | lnc-SFPQ-2:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003070 | SNORD89 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CCNJ-1:6 | lnc-CCNJ-1:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000514571 | MEF2C-AS1-213 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_123730 | LOC339260 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623581 | AC244517.12-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF800-5:1 | lnc-ZNF800-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038432 | LOC100506274 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PPIL2-2:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RHOF-1:22 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000453179 | LINC02828-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_125872 | LOC101928307 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TEKT3-1:1 | lnc-TEKT3-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000609491 | AC064836.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FGF10-3:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-LRAT-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FAM86C1-1:3 | lnc-FAM86C1-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AL353791.1.1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000573950 | TAPT1-AS1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC110080.1-17:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ANO3-5:1 | lnc-ANO3-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-BRD2-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038902 | JAKMIP2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZFPM2-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000509463 | FAM198B-AS1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_024256 | GATA3-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000503140 | LINC02268-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-C12orf75-5:1 | lnc-C12orf75-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PROM2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110744 | ZIM2-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034182 | MATN1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623764 | AC022784.6-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC005609.1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000567862 | AC009081.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SUV420H1-2:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-FOXC1-12:1 | lnc-FOXC1-12:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-P4HA2-3:4 | lnc-P4HA2-3:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TRIM29-3:1 | lnc-TRIM29-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT055957.2 | NONHSAT055957 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FRG1-5:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C19orf29-AS1-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000512370 | AC097515.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000454631 | AL445524.1-208 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000624795 | AC105114.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM70A-1:9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000553678 | AL049775.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038259 | TPTE2P5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000569460 | AL359851.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033872 | PCBP1-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000514241 | MAST4-IT1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-COL8A1-3:1 | lnc-COL8A1-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000457870 | PCBP1-AS1-241 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000615619 | AL160412.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000421112 | AC064875.1-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000589360 | AC005786.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CDC73-2:1 | lnc-CDC73-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SCRT2-1:1 | lnc-SCRT2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF266-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT101554 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000591379 | AC011591.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000452919 | CHL1-AS2-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606967 | AL451050.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DEC1-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PRKCDBP-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT069232.2 | NONHSAT069232 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-RRM2B-7:1 | lnc-RRM2B-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RNASEH2B-3:39 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_047662 | LOC729732 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C1orf133-1:7 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000489557 | AC016746.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-AC025287.1-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-KAT6A-3:1 | lnc-KAT6A-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046242 | LINC00920 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT127683.2 | NONHSAT127683 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_022011 | PWARSN | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C3orf65-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000614751 | AC005746.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000518129 | AC037450.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000445300 | AL034417.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SAA2-4:1 | lnc-SAA2-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF514-10:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MRPL43-1:1 | lnc-MRPL43-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TTC12-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002139 | HCG4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MRGPRF-2:1 | lnc-MRGPRF-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-OR4F6-1:4 | lnc-OR4F6-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-C5orf63-1:4 | lnc-C5orf63-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000560148 | CCDC33-208 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_028344 | LINC00632 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP1-228P16.5.1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MAGEE2-1:3 | lnc-MAGEE2-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-COL9A3-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF717-5:1 | lnc-ZNF717-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ADCY4-1:1 | lnc-ADCY4-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-EMP3-1:4 | lnc-EMP3-1:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MRE11A-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000598131 | AC008554.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_021485 | EGFEM1P | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-VEZT-1:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000438115 | AC012368.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033903 | MED15P9 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT059050.2 | NONHSAT059050 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_073084 | CRIP2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034007 | LINC00880 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GRHL2-7:5 | lnc-GRHL2-7:5 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_109954 | BAALC-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM135A-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_034019 | TP53TG3HP | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-BICD1-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-XRCC2-3:1 | lnc-XRCC2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000414377 | AL078645.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000610394 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-EIF2AK3-4:28 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-NOG-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT018889 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026774 | LINC00239 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000452471 | AC005009.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000454538 | AL136456.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CXorf28-6:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_038251 | DPH6-DT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-INSC-6:1 | lnc-INSC-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000450445 | BNC2-AS1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000526385 | LINC02713-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000564697 | Z97205.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CCDC140-1:6 | lnc-CCDC140-1:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000613309 | BX255923.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C8orf83-7:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SKAP2-1:1 | lnc-SKAP2-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT143842.2 | NONHSAT143842 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GOLGA6L6-6:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000522264 | AL160262.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000610170 | Z73429.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-UST-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PCDH9-13:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-UMODL1-2:8 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM149B1-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-MRPS5-14:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-METTL13-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TIAL1-1:2 | lnc-TIAL1-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000422683 | AC073987.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_028328 | ELMOD1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046535 | GPC6-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-ZNF506-1:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PBX1-3:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046312 | KIAA1656 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000583497 | AP000829.1-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000605849 | AC106881.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-160N1.10.1-8:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C10orf31-10:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT023724.2 | NONHSAT023724 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT137101 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-PTRH2-2:1 | lnc-PTRH2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000500076 | AC010198.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-NDNF-1:1 | lnc-NDNF-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-LEPR-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SERPINA5-1:1 | lnc-SERPINA5-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000600805 | AC026202.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046326 | PCAT6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GTF3A-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046625 | MEIS1-AS2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-HSD17B14-3:2 | lnc-HSD17B14-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-6F2.7.1-2:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-ZNF860-2:1 | lnc-ZNF860-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT117452.2 | NONHSAT117452 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_002834 | DUSP5P1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000607781 | RN7SL832P-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CCDC74A-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120619 | LINC01163 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-TPRG1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000592319 | AC016590.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SETD4-12:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | NONHSAT023557 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-TRIM71-2:1 | lnc-TRIM71-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000552933 | DDN-AS1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-CCDC82-4:1 | lnc-CCDC82-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RNF2-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-664D7.4.1-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000435271 | AC022537.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_040058 | RAD51-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MRGPRF-4:6 | lnc-MRGPRF-4:6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000524017 | AC068672.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000456087 | STARD13-IT1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_108074 | LINC00706 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FRG1-5:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_120532 | LOC101929427 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-DYRK2-6:2 | lnc-DYRK2-6:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-CXorf28-3:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000430844 | AC073343.2-202 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-PAM16-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000606754 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000507627 | AC010395.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SUZ12-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000511707 | LINC01411-205 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000597288 | AC009955.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623854 | AC009229.4-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RNF13-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-WDSUB1-1:1 | lnc-WDSUB1-1:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110152 | ZNF585A | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000514846 | PRR7-AS1-204 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-RP11-195B21.3.1-6:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM108B1-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-STARD4-4:2 | lnc-STARD4-4:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C2orf42-3:67 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FAM27E2-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT139031.2 | NONHSAT139031 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-F7-5:3 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000600183 | AC021504.1-208 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-GRASP-2:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000505498 | AC110800.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SLC10A7-5:1 | lnc-SLC10A7-5:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-SLC24A4-3:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_045115 | MLLT10P1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NONHSAT077117.2 | NONHSAT077117 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000547326 | AC121761.1-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-DLX6-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-C6orf164-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-IRAK3-4:1 | lnc-IRAK3-4:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-MAG-1:2 | lnc-MAG-1:2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_003341 | SNORD116-27 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_122044 | SH3TC2-DT | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_110069 | LOC101927021 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-GPATCH2-6:4 | lnc-GPATCH2-6:4 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000602211 | NA | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000561705 | LINC02562-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_046681 | PDZRN3-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000616071 | AP003419.3-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000439406 | HCG20-208 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_040079 | LINC02649 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000623938 | AC068254.2-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-USP9X-7:1 | lnc-USP9X-7:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000452465 | C1orf61-207 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NA | lnc-FOXD4L5-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_033691 | ZNF436-AS1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_026548 | TSPEAR-AS2 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| NR_102308 | CACNG6 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000618125 | AC025164.1-203 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| lnc-SERPINA12-2:1 | lnc-SERPINA12-2:1 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |
| ENST00000554773 | LINC02322-201 | DB00853 (APRD00557) | temozolomide | glioblastoma | resistant | 31053733 | more... |